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ABSTRACT 
Matthew James Smola: Structure-Function Relationships of Long Non-Coding RNAs in Living Cells 
(Under the direction of Kevin M. Weeks) 
 
From the beginning of the era of molecular biology in the 1960s until the 1980s, RNA was 
widely regarded as a passive cellular messenger. However, the importance of RNA has been steadily 
emerging over the last 30 years and we now know that it is often a critical and central component of 
genetic regulation. Recently, long non-coding RNAs (lncRNA) have become the focus of intense research 
because of their roles in development and disease. For most functional RNAs, complex structural 
characteristics underlie the biological function of the molecule. However, the difficulty of de novo RNA 
structure prediction and the relatively low abundance of lncRNA transcripts have been roadblocks to 
experimental structure probing. As a result, very little is known about the structural features of lncRNAs. 
In this work, I present experimental and analytical methods that enable chemical structure probing of rare 
RNA transcripts and identification of stable RNA-protein interaction sites. First, I show that polymerase 
chain reactions can be used as an enrichment strategy that faithfully maintains structure-probing data. I 
then outline an analytical framework that enables statistically rigorous detection of RNA-protein 
interactions in living cells. Finally, I apply these new methodologies to the Xist lncRNA and present a 
data-driven secondary structure model that highlights the extensive structures present throughout the 
transcript. I then identify nearly 200 specific sites where Xist is strongly impacted by the cellular 
environment and use them to identify several new protein interaction domains within Xist. Together, this 
work provides new experimental and analytical tools, as well as many new insights on the relationship 
between lncRNA structure and function, that will enable rapid study of lncRNA structures in the future.   
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“When we recognize our place in an immensity of light-years and in the passage of ages, 
when we grasp the intricacy, beauty, and subtlety of life, then that soaring feeling, 
that sense of elation and humility combined, is surely spiritual.” 
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CHAPTER 1: THE RELATIONSHIP BETWEEN RNA STRUCTURE AND FUNCTION 
Hierarchy of RNA structure 
Ribonucleic acid (RNA) has been the focus of an extended scientific renaissance that has been 
gradually building momentum over the past 25 years (1). While originally thought to act as a simple, 
passive intermediate between genetic information stored in the nucleus and the protein synthesizing 
components of the cytoplasm, we now know that RNA is actively and critically involved in modulating 
gene expression through a variety of mechanisms (2). These modes of action can be cis- or trans-acting 
and can be carried out by the RNA alone or require additional protein partners. It has been discovered that 
RNA can regulate gene expression through alternative RNA splicing (3), RNA interference (4, 5), and by 
the action of riboswitches (6) and long non-coding RNA (lncRNA) (7). 
Underlying many of these functions is the ability of RNA molecules to adopt complex structures 
(8). RNA structure is hierarchical: structural elements at one level provide the foundation for higher-order 
structures (9). The simplest, primary structure of an RNA is defined by the specific linear sequence of 
individual nucleotides that comprise the full-length molecule. This sequence can be any combination of 
the four RNA nucleotides: adenosine (A), cytosine (C), guanosine (G), and uracil (U) (Fig. 1.1a). These 
are often described as the “letters” of the RNA “alphabet.” In some roles, RNA function is driven largely 
by primary structure (e.g. RNA silencing). However, higher levels of RNA structure can both tune these 
functions and enable more complex activities. 
The secondary structure of RNA refers to the ability of individual RNA molecules to fold and 
interact with themselves. Secondary structures are defined by hydrogen bonding interactions between 
pairs of nucleotides. Only certain pairs are able to form stable interactions and canonically, these are 
formed by G-C, A-U, and G-U pairs (Fig. 1.1b). Consecutive base pairs form a double helix structure 
  
Figure 1.1 Elements and heirarchy of RNA structure. (a) The four RNA nucleotides. All nucleotides 
have phosphate (orange) and ribose sugar (black) moieties in common, while the nitrogenous base (blue) 
determines the chemical identity of each nucleotide. (b) The canonical base pairs of RNA. Pairing is 
faciliated by hydrogen bonding (red dashed lines) between the nitrogenous bases of two nucleotides. A-U 
(left) and G-C (center) pairs are analogous to those found in DNA, while G-U pairs (right) are unique to 
RNA. (c) The heirarchy of RNA structure. The primary, secondary, and tertiary structure of the thiamine 
pyrophosphate riboswitch are shown. Primary structure is defined by the linear sequence of nucleotides 
(left). Base pairing interactions between distant elements of primary structure (indicated by lines 
connecting colored nucleotides) lead to helix formation and the secondary structure of an RNA (center). 
Examples of a bulge, junction, and loop are labeled. In many cases, RNA secondary structure leads to the 
formation of well-defined three-dimensional structures (right). The precise three-dimensional 
arrangement of the riboswitch tertiary structure enables recognition and binding of a small ligand, shown 
as purple spheres (PDB ID: 2GDI). Nucleotides that form helices are color-coded throughout. 
 3 
and, in many RNAs, multiple helical elements are connected by unpaired nucleotides to form loops, 
bulges, and junctions (Fig. 1c). In most cases, the secondary structure of an RNA strongly affects its 
tertiary structure This highest level of RNA structure is defined in three dimensions and is modulated by 
the length and placement of helices, loops, bulges, and other structural elements (9) (Fig. 1c). Tertiary 
structures can be stabilized by and, in many cases, facilitate interaction with proteins, small molecule 
ligands, and metal ions (10). RNA tertiary structures often play critical roles in biology. For example, 
riboswitches are a class of RNA elements that fold into well-defined tertiary structures and specifically 
recognize small metabolites (6). The binding and release of these metabolites induces dramatic three-
dimensional structure changes that regulate gene expression.  
Since RNA structure is closely linked to function, structural characterization of an RNA is often 
the first step to understanding how it operates. Experimentally determining the tertiary structure of an 
RNA can be an arduous undertaking, and the computational tools needed to predict such structures de 
novo are both resource-intensive and imperfect. However, even secondary structure can be highly 
informative of the function of an RNA (11), and several efforts to improve RNA secondary structure 
prediction have been successful (12). For this reason, and because secondary structure provides the 
foundation for tertiary structure, most investigations into RNA structure-function relationships focus on 
secondary structure. However, until recently, most RNA structure work has focused on abundant RNAs. 
Although biologically critical in many cases, rarer transcripts have been largely ignored in favor of those 
that are more easily accessible. 
The rise of lncRNAs as effectors of genetic regulation 
Recently, advances in sequencing technology have enabled rapid and unprecedented studies on 
the composition of mammalian DNA genomes and RNA transcriptomes. One of the most striking results 
of these studies is that while roughly 75% of the human genome is transcribed into RNA (13), less than 
2% is translated into proteins (14). The resulting interpretation is that the remainder of the transcriptome 
functions in a non-coding capacity. While a handful of non-coding RNAs such as ribosomal RNA, 
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transfer RNA, and small nuclear RNA have been well-known for years, new families of non-coding 
RNAs are being continually discovered (15). Of particular interest are the long non-coding RNAs 
(lncRNAs), defined as transcripts longer than 200 nucleotides with little to no coding potential (7). This 
class of RNA is frequently associated with epigenetic regulation of chromatin (16), but the list of cellular 
roles ascribed to lncRNAs now includes transcriptional regulation, modulation of protein activity, 
organization of protein complexes, and intercellular signaling (17). lncRNAs exhibit cell type-specific 
expression patterns (18) and are associated with several diseases, including cancer (19). As a result, 
lncRNAs have been the focus of intense research in the last decade. 
In performing various regulatory functions, lncRNAs often interact with protein complexes and 
genomic DNA (7, 17, 20, 21). The nature of these interactions can vary greatly. For example, lncRNAs 
such as Xist, HOTAIR, and Kcnq1ot1 act as molecular scaffolds to coordinate histone modifying 
complexes and silence specific regions of the genome (22-24) (Fig. 1.2a). In other cases, lncRNAs can 
act as molecular sponges and sequester RNA polymerase II or transcription factors, reducing gene 
transcription (25, 26) (Fig. 1.2b-c). Occasionally the lncRNA itself is not important; rather, the process of 
lncRNA transcription negatively affects antisense genes at the same locus (27) (Fig. 1.2d). Alternatively, 
some lncRNAs have been found to interact directly with genomic DNA, inhibiting the binding of 
transcription complexes (28) (Fig. 1.2e). Finally, not all lncRNA actions are repressive. For example, 
Evf-2 recruits a transcriptional activator to specific DNA regulatory elements, leading to increased 
transcription at those loci (29) (Fig. 1.2e).  
Although it is clear that lncRNAs regulate gene expression at transcriptional, post-transcriptional, 
and epigenetic levels, there are many unanswered questions regarding lncRNA structure and function: 
Why are lncRNAs so long? Do lncRNAs have well-defined structures? If so, to what extent does the 
cellular environment modulate structure? What features govern lncRNA-protein interactions? While 
lncRNAs are often described as having modular structure (20), only two lncRNAs have been structurally 
characterized to date: the steroid receptor RNA activator (SRA) and HOTAIR (30, 31). These lncRNAs 
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Figure 1.2 Example mechanisms of lncRNA gene regulation. (a) Recruitment of histone modifying 
complexes by lncRNAs leads to deposition of activating (left, purple) or repressing (right, orange) histone 
modifications. (b) Direct interaction between lncRNAs and RNA polymerase (Pol) inhibits transcription. 
(c) lncRNAs sequester transcription factors (TF) and prevent gene expression. (d) Transcription of 
lncRNA inhibits expression of antisense genes at the lncRNA locus. (e) lncRNAs interact with genomic 
DNA to block transcription factors and repress gene expression. (f) lncRNAs enhances gene expression 
by coordinating the recruitment of TFs.  
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are 0.87 and 2.1 kilobases (kb) long, respectively, and indeed adopt modular structures. However, they 
represent simple systems relative to other lncRNAs. For example, the Xist lncRNA is roughly an order of 
magnitude greater in length and associates with more than 50 proteins in order to silence an entire 
chromosome in a process called X-chromosome inactivation (XCI) (24, 32-35). Although XCI has been 
researched for more than 50 years (36) and the central role of Xist in this process was discovered 20 years 
ago (24, 35), the structural architecture of this lncRNA has yet to be determined. As an archetype of 
lncRNA-mediated genome silencing, structural characterization of Xist would provide an excellent 
foundation for understanding structure-function relationships in lncRNAs. 
Methods for interrogating RNA secondary structure 
For many years prior to the realization that RNA can form functional structures, most 
biochemical structure studies were performed on proteins using high-resolution (and labor-intensive) 
methods such as x-ray crystallography. For many proteins, the diverse array of hydrophobic and 
hydrophilic surfaces enables formation of suitable crystals. Unfortunately, the relatively uniform surface 
features and flexibility of RNA create significant challenges for crystallographers, so much so that many 
alternative structure-probing methods have been developed. 
The goal of most RNA structure probing strategies is to discriminate, experimentally, base-paired 
nucleotides from single-stranded nucleotides. Generally, this is accomplished by using structure-selective 
RNases or small chemical probes. RNases are protein enzymes that recognize and cleave RNA; several 
RNases with structure-specific behaviors have been identified (37). Although once widely used for RNA 
studies, the activity of these bulky enzymes can be biased by factors unrelated to RNA structure, 
decreasing the accuracy of experimental results (37). 
Small molecule reagents have become a popular alternative to enzymatic structure probing. The 
small size, relatively simple chemistry, and structural selectivity of these reagents enable accurate 
interrogation of RNA structure. Generally, RNA structure probes react selectively with flexible 
nucleotides, allowing for the discrimination of constrained and flexible nucleotides. Reagents used in 
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early experiments react with the nucleobase moieties of RNA and include dimethyl sulfate (DMS), which 
reports on A and C nucleotides (38, 39) (Fig. 1.3a); 1,1-dihydroxy-3-ethoxy-2-butanone (kethoxal), 
which reports on G nucleotides (40) (Fig. 1.3b); and 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide 
metho-p-toluenesulfonate (CMCT), which reports on G and U nucleotides (41) (Fig. 1.3c). While 
together these reagents yield structure information on all four RNA nucleotides, a major disadvantage is 
that obtaining a complete dataset for all four nucleobases requires optimization of reaction conditions for 
each reagent, including incubation time, buffer conditions, reagent concentration, and reaction quenching. 
In many cases, researchers settle for either DMS or CMCT, as these each yield data for two of the four 
RNA bases. 
In the last decade, a suite of chemical reagents that react specifically with the 2ʹ′-hydroxyl moiety 
of flexible RNA nucleotides has been developed (42-44) (Fig. 1.3d). Unlike base-specific probes, these 
acylating reagents report on all four RNA bases since every nucleotide carries a 2ʹ′ hydroxyl. This 
approach to RNA chemical probing, known as SHAPE (selective 2ʹ′-hydroxyl acylation analyzed by 
primer extension), typically makes use of isatoic anhydride derivatives, including 1-methyl-7-nitroisatoic 
anhydride (1M7), 1-methyl-6-nitroisatoic anhydride (1M6), and N-methylisatoic anhydride (NMIA). 1M7 
is generally considered the “workhorse” of SHAPE reagents and accurately reports on local nucleotide 
flexibility (43), while 1M6 and NMIA are often used in combination with 1M7 to reveal nuanced details 
of RNA structure (44, 45). 
SHAPE reagents have many advantages over other chemical probes. They are self-inactivating 
via competing hydrolysis with water and thus require no specific quench step. They are unaffected by the 
presence of small molecules or proteins, and are compatible with most biologically relevant in vitro 
solution conditions. SHAPE reagents also perform well in complex environments, such as those within 
virus particles (46-51) and living cells (52-55). 
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Figure 1.3 Examples of RNA structure-probing reagents. (a) DMS modification of A and C 
nucleotides yields addition of a methyl group on the base-pairing edge of the nucleobase. (b) Reaction of 
G nucleotides with kethoxal produces a bulky cyclic adduct that blocks base pairing. (c) CMCT 
modification of G and U nucleotides produces an extensively bulky adduct. Each R group contains a 6-
membered aliphatic ring. (d) SHAPE reagents react with the 2ʹ′-hydroxyl to form a bulky 2ʹ′-O-adduct and 
are thus capable of probing all four nucleotides simultaneously. The R1 and R2 groups can vary based on 
the application.  
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Perhaps one of the greatest advantages of SHAPE reagents over other chemical probes is their 
ability to accurately constrain computational predictions of RNA secondary structure. For very small 
RNAs, computer algorithms can use thermodynamic parameters to model generally accurate structures. 
However, as the size of the RNA increases, the number of possible base-pair combinations also increases 
and computational prediction accuracy decreases dramatically. Since SHAPE chemical probing data 
report on RNA structure, they can be used to guide structure prediction software and result in highly 
accurate structure models (45, 56, 57). In addition, structure modeling of large RNA transcripts has been 
robustly automated such that data-driven structure models and analysis can be easily generated within a 
few hours (50, 58). 
Coupling RNA structure probing to massively parallel sequencing 
Until very recently, the results of RNA chemical probing experiments were read out by annealing 
a labeled primer to the RNA of interest and extending the primer with reverse transcriptase to create a 
complimentary DNA (cDNA) strand. Under normal conditions, reverse transcriptase enzymes are blocked 
by chemical adducts or RNase cleavage sites. Thus, when a sample of RNA molecules is probed and 
analyzed by primer extension, the length and abundance of each cDNA species relates to the position and 
intensity of chemical modification or cleavage, respectively. Using labeled primers, these cDNAs are 
resolved and quantified using gel or capillary electrophoresis. 
While a small amount of sample multiplexing is possible with this approach, experiments read 
out by electrophoresis are usually limited to studying a single RNA at a time. Due to signal decay, 
multiple primers must be used to study large RNAs, which introduces the additional challenge of 
accurately merging data from individual reactions into a contiguous data set. As the number of primer 
extension reactions increases, the material requirements also increase; a 2009 study of the ~9,000 
nucleotide HIV RNA genome required nearly 300 µg of RNA purified from 19 L of virus culture (47). 
The recent and rapid development of massively parallel sequencing (MPS) technology has 
dramatically changed how nucleic acids are sequenced and analyzed. Instead of sequencing a single DNA 
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of interest, modern instruments sequence sample libraries containing millions of individual DNA 
fragments simultaneously. Most commercial platforms require specific adaptor sequences on the 5ʹ′ and 3ʹ′ 
ends for initial recognition by the instrument. Thus, it would appear as though all that is needed to couple 
RNA structure probing with MPS technology is to construct sequencing libraries that quantitatively 
preserve the 3ʹ′ termini of cDNAs generated during primer extension. Several research laboratories have 
developed methods that aim to achieve this type of massively parallel structure probing (Table 1.1). 
However, most of these methods rely on ligation steps that are biased in unpredictable ways, making them 
difficult to correct (71, 72). As a result, sequencing libraries generated in this fashion may not preserve 
the original chemical probing data with high fidelity. 
To date, only one approach, called mutational profiling (MaP), offers an alternative strategy for 
quantifying the position and intensity of RNA structure probe reactivity. Instead of performing 
conventional primer extension in which reverse transcriptase is blocked by adducts, MaP exploits the 
ability of reverse transcriptase enzymes to proceed through chemical adducts in the presence of divalent 
manganese. Under MaP conditions, when reverse transcriptase encounters a site of modification it is more 
likely to incorporate a nucleotide non-complimentary to the original RNA sequence in the nascent cDNA 
strand. These sequence mutations are thus permanently and securely embedded within the cDNA, 
rendering MaP experiments impervious to common downstream library preparation biases. MaP has been 
coupled with SHAPE and DMS chemical probing (50, 70). Data generated by the SHAPE-MaP approach 
are of as high (or higher) quality than data obtained by prior gold-standard capillary electrophoresis 
methods (50) and, unlike other massively parallel structure probing approaches, can be used to accurately 
predict RNA secondary structures (50, 58). 
Research overview 
The overarching vision of this work is to address the role of RNA structure within the context of lncRNA 
function. Using the Xist RNA as an example, I highlight how lncRNAs can adopt stable secondary 
structures and, by comparison of in-cell and ex vivo data, show that these structures likely play a critical  
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Name Probe System Citation Detection of modifications 
PARS RNase S1, RNase V1 Yeast, Human (59) 
Reverse transcriptase stops 
(cDNA 3ʹ′ ends) 
Frag-seq RNase P1 Mouse (60) 
SHAPE-seq 1M7 Synthetic, Bacteria (61) 
MAP-seq 1M7, CMCT, DMS Synthetic (62) 
HRF-seq Hydroxyl radical Bacteria (63) 
ChemMod-seq 1M7, DMS Yeast (64) 
CIRS-seq CMCT, DMS Mouse (65) 
Structure-seq DMS Plant (66) 
DMS-seq DMS Yeast, Human (67) 
Mod-seq DMS Yeast (68) 
icSHAPE NAI Mouse (69) 
SHAPE-MaP 1M7 HIV, HCV (50) Mutational profiling 
(cDNA internal mutations) RING-MaP DMS Synthetic (70) 
 
Table 1.1 Approaches for massively parallel RNA structure probing. Numerous approaches have 
been developed in order to merge MPS and RNA structure probing. These various methods employ both 
nuclease and chemical probes, and most focus on detecting the 3ʹ′ ends of cDNA produced when reverse 
transcriptase encounters a chemical adduct or cleavage site. The MaP approach is unique in that it records 
chemical modifications as mutations internal to the cDNA sequence.  
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role in coordinating and modulating protein interactions in cells. In the course of this work, it was 
necessary to invent new solutions in order to obtain the necessary data. As such, my overall work toward 
understanding lncRNA structure has led to new experimental and computational methods for obtaining 
and analyzing SHAPE data. 
In Chapter 2, I outline a novel approach for studying the structures of low-abundance RNAs with 
SHAPE-MaP. To properly characterize RNA structure by chemical probing, it is necessary to sufficiently 
sample the original pool of RNA molecules. While many RNAs are abundant enough that probing total 
cellular RNA yields high-quality structure data, the vast majority of transcripts are present at low levels 
and must be enriched or isolated prior to study. I show that PCR amplification prior to library 
construction can be used to extract chemical probing data for RNAs of interest. This allows for rapid and 
efficient analysis of rare, native RNA transcripts without the need for specialized pull-downs and with 
relatively low input material requirements. 
In Chapter 3, I address the challenge of rigorously evaluating changes in SHAPE reactivity 
between two experimental conditions, focusing on detecting effects of the cellular environment on RNA 
structure. Using the built-in error estimates of SHAPE-MaP, I outline an analytical framework that 
identifies strong, significant changes in SHAPE reactivity. I validate this approach, called ΔSHAPE, with 
the U1 snRNA, 5S rRNA, and signal recognition particle, showing that ΔSHAPE analysis results in 
robust and correct identification of RNA-protein interaction sites. Finally, I apply ΔSHAPE to the RNA 
component of RNase MRP and show that this analysis detects previously-known RNA-protein 
interactions and identifies new contacts unaccounted for by current models. 
Chapter 4 focuses on my overall vision of understanding lncRNA structure-function relationships 
via the Xist RNA. I first present a data-driven model of Xist and highlight how much of the RNA is 
involved in stable secondary structures, which may rationalize the conserved length of the RNA among 
mammals. I show that previously identified functional regions appear to sample a variety of structures, 
and I identify new portions of the transcript that undergo extensive structural changes in the cellular 
environment. Using ΔSHAPE analysis, I identify nearly 200 specific sites where Xist is strongly impacted 
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by the cellular environment. Cross-referencing these sites with protein binding databases, I then identify 
several new protein interaction domains within Xist. Overall, this work provides many new insights on the 
relationship between RNA structure and function in lncRNAs. It shows that lncRNAs can adopt stable 
structures, that these structures modulate protein interactions in several specific ways, and that RNA 
chemical probing can be used to identify novel regions of interest even in Xist, an RNA that has been 
extensively studied for twenty years.  
Perspective 
The notion that form follows function is pervasive in all of biology. At every scale, from 
opposable thumbs, to the valves and chambers of the heart, down to the intricate atomic arrangement of 
an enzyme active site, the physical structures of biology are tightly linked to their functions. In this work, 
I apply principles from molecular biology, biochemistry, and biophysics in order to broaden our 
understanding of this structure-function relationship in the Xist lncRNA. In doing so, I have developed 
broadly useful approaches for accessing the chemical probing profiles of rare RNAs and for rigorously 
detecting chemical probing differences ex vivo and in living cells. In applying these advances to Xist, I 
have created a useful model that highlights how structure and function converge in the context of this 
RNA. 
We have only recently begun to understand and appreciate the extent to which lncRNAs work to 
modulate gene expression. My hope is that the work presented here will provide useful methodologies 
and serve as a starting point and touchstone for future studies. As we work to further understand the 
intricacies of Xist-mediated genome silencing, I anticipate that the model of Xist structure-function 
relationships presented here may act as a “molecular roadmap,” highlighting functional regions of the 
RNA worthy of additional study. I also hope that this work will be a helpful guide as researchers make 
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CHAPTER 2: ACCESSING SHAPE-MAP PROFILES OF RARE RNA TRANSCRIPTS1 
Introduction 
RNA plays many fundamental biological roles and interacts with small-molecule ligands, 
proteins, and other RNAs (1). In these roles, RNA molecules must adopt specific secondary and tertiary 
structures, the details of which are often difficult or impossible to characterize from sequence alone. 
Chemical probing techniques have proven to be powerful tools for understanding the critical features of 
RNA structure at both small and large scales. SHAPE (selective 2ʹ′-hydroxyl acylation analyzed by primer 
extension) uses small hydroxyl-selective electrophilic reagents to probe the reactivity of the RNA ribose 
2ʹ′-OH group. SHAPE reactivities are insensitive to base identity and measure local nucleotide flexibility 
and dynamics (2-4) because flexible residues sample a wide range of conformations, a subset of which 
enhance the reactivity of the 2ʹ′-hydroxyl (5) (Fig. 2.1a). 
SHAPE chemistry makes it possible to examine RNA structure in an especially thorough way 
because, with the exception of some post-transcriptionally modified RNAs, all RNA nucleotides carry a 
2ʹ′-hydroxyl group. SHAPE reactions are self-inactivating via a competing hydrolysis reaction with water 
(Fig. 2.1b) and thus require no specific quench step. Because few compounds have a net reactivity as high 
as 55 M water, intrinsic SHAPE reactivities are largely insensitive to the presence of (additional) 
competing small molecules, ligands, and proteins. SHAPE experiments work robustly when performed in 
complex environments including those inside virions  (6-8) and in living cells  (9, 10). By careful choice 
of SHAPE reagent  (9-11) and experimental design, nucleotide flexibilities can be compared under 
                                                      
1 The text and figures in this chapter are adapted from a publication written in collaboration with two colleagues. My 
critical contributions were the development of an amplicon-based strategy to enrich for low-abundance RNAs and 
the implementation of rapid, transposase-mediated library construction techniques. Elements of this chapter 
originally appeared in: M.J. Smola, S. Busan, G.M. Rice, N.A. Siegfried, and K.M. Weeks, Selective 2ʹ′-hydroxyl 
acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) for direct, versatile, and accurate 
RNA structure analysis. Nature Protocols. 10, 1643-1669 (2015). 
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Figure 2.1 SHAPE chemistry and useful SHAPE reagents. (a) SHAPE reagents react preferentially 
with the 2ʹ′-hydroxyl groups of conformationally flexible RNA nucleotides. (b) Quenching of SHAPE 
reagents via hydrolysis. (c) Overview of the three most useful SHAPE reagents. 1M7 is the workhorse 
SHAPE reagent; its reactivity with RNA measures local nucleotide flexibility. 1M6 and NMIA are 
selective for nucleobases that have one face available for stacking and that achieve a reaction-competent 
conformation on a slow timescale, respectively. Together, 1M6 and NMIA can be used to detect non-




different experimental or environmental conditions, including cell-free versus in-cell and as a function of 
ligand and protein binding. SHAPE reactivity information used as constraints in RNA modeling 
algorithms results in accurate secondary structure models  (12-14). 
To enable identification of sites of SHAPE modification using high-throughput sequencing, we 
developed a strategy termed mutational profiling or MaP. In MaP, specialized primer extension 
conditions allow reverse transcriptase to read through SHAPE-modified nucleotides without termination 
of the nascent cDNA strand (15). The bulky 2ʹ′-O-adduct at modified RNA positions induces 
incorporation of a nucleotide non-complimentary to the original RNA sequence at the corresponding 
position in the newly synthesized cDNA. Thus, during reverse transcription, the positions and relative 
frequencies of SHAPE adducts are directly and permanently encoded as mutations in the cDNA sequence. 
Two control experiments are performed in parallel (15): (i) a no-reagent control to characterize the 
background mutations resulting from the MaP procedure and (ii) a denaturing control, in which the RNA 
is modified roughly evenly along its length, to measure position-specific differences in adduct detection. 
Ultimately, MaP is largely impervious to the substantial sequence- and structure-based biases that are 
introduced during construction of the libraries required for massively parallel sequencing. Because the 
reverse transcriptase enzyme reads through the chemical adducts, the MaP approach is also insensitive to 
single-strand breaks or background degradation, and does not exhibit signal decay or drop-off, effects that 
result in significant noise in other high-throughput sequencing-based strategies for detecting chemical 
modification of RNA. 
All current information supports the view that the MaP approach represents a no-compromises 
strategy for reading out the results of an RNA structure probing experiment by massively parallel 
sequencing. SHAPE-MaP was validated using a test set of RNAs ranging in size from 75 to 3,000 
nucleotides. SHAPE-MaP was then recently used to analyze the entire HIV-1 RNA genome (~9,200 nt) 
(15). The new model recapitulates all previously known and accepted functional motifs and, moreover, 
identifies multiple new structural motifs including three experimentally validated pseudoknots. 
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MaP allows RNAs of virtually any size to be analyzed in a single experiment, facilitates high 
levels of multiplexing, and permits fully automated data analysis (15). Because the region under 
interrogation is completely sequenced in each read, sequence differences are revealed directly; therefore, 
the effects of sequence polymorphism and co-existing ribosnitches (15) can be evaluated in single 
experiments. The MaP experiment includes a DNA amplification step; therefore, individual RNAs 
present in scarce amounts, or in complex mixtures, can be examined. In sum, SHAPE-MaP yields robust 
nucleotide-resolution RNA structural information, enables accurate secondary structure modeling, can 
deconvolute sequence polymorphisms in a single experiment, readily allows analysis of low-abundance 
RNAs, and scales gracefully from short RNAs to transcriptome-wide analyses. We anticipate that 
SHAPE-MaP will contribute to deep understandings of the relationships between RNA structure and 
function.  
Experimental design 
SHAPE-MaP yields quantitative SHAPE reactivity data for nearly every position in an RNA by 
combining the well-validated SHAPE acylation reaction with specialized reverse transcriptase conditions 
and deep sequencing. Once the MaP step is complete the RNA structure information is converted to DNA 
sequence information that is largely immune to biases and artifacts introduced during the steps required to 
convert the original cDNAs into the libraries required by any specific sequencing platform. Here we 
describe protocols for SHAPE probing, mutational profiling, and three library construction approaches 
based on Illumina sequencing (Fig. 2.2). The relative merits of the library construction approaches are 
governed by the length and amount of the RNA of interest. 
RNA folding and modification 
SHAPE-MaP may be applied to RNAs of any length or complexity; however, since SHAPE 
modification inherently probes an ensemble of RNA molecules, it is critical to give careful thought to 
ensure that the RNA sample is folded in a biologically relevant and informative state prior to 
modification. For in vitro-transcribed RNA, suitable folding conditions have been described (2, 16, 17).
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Figure 2.2 Overview of SHAPE-MaP workflows. RNAs are modified with a SHAPE reagent and 
subjected to reverse transcription under MaP conditions, during which adduct-induced mutations are 
recorded in the cDNA strand. One of three workflows is then used to construct high-quality libraries for 
sequencing and recovery of the SHAPE chemical probing information. 
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Methods for extraction, and purification of large, complex RNAs from virions (6-8, 18) and cells (10, 12) 
under native-like conditions have been described. RNA should be maintained under conditions likely to 
retain pre-existing RNA secondary and tertiary structure and use of denaturants, divalent ion chelators, or 
elevated temperature should be avoided. Direct interrogation of RNA structure directly inside cells by 
SHAPE is also well-established (9, 10, 19). This protocol emphasizes simple folding procedures for 
interrogating native-like and deproteinized RNAs, but any procedure that folds an RNA into an 
informative state can be used, provided the pH is in the 7.4-8.3 range. 
Any SHAPE reagent can be used to modify RNA in a SHAPE-MaP experiment. In this protocol, 
we emphasize the use 1-methyl-7-nitroisatoic anhydride (1M7). Essentially identical approaches can be 
used with reagents 1-methyl-6-nitroisatoic anhydride and N-methyl-isatoic anhydride (1M6 and NMIA, 
respectively; Fig. 2.1c) (14). Reactions with 1M6 and NMIA are selective for nucleotides in which one 
face of the nucleobase is available for stacking and that undergo relatively slow conformational changes, 
respectively. These reagent-specific reactivities can be used both to identify residues that participate in 
non-canonical interactions and to improve RNA secondary structure modeling (14, 20). In addition, the 
MaP strategy can also be used to follow time-resolved RNA processes, in 1-sec snapshots, using the 
benzoyl cyanide (BzCN) reagent (21). The modest solubility and rapid hydrolysis of these reagents make 
over-modification of RNA samples virtually impossible. 
SHAPE electrophiles are added to the folded RNA (or virus or cell) and then incubated until the 
reagent has either reacted with RNA or degraded via hydrolysis with water (5 hydrolysis half-lives, 
Fig. 2.1b-c). Two additional reactions are performed in parallel: a no-reagent control and a denaturing 
control. In the no-reagent control reaction, folded RNA is incubated with solvent only (typically DMSO 
for SHAPE reagents); this control is used to measures the intrinsic background mutation rate of reverse 
transcriptase under MaP conditions. In the denaturing control reaction, RNA is suspended in a denaturing 
buffer containing formamide and incubated at 95 °C prior to modification with SHAPE reagent. 
Nucleotides are modified relatively evenly in this step, and the resulting site-specific mutation rates 
directly account for sequence- and structure-specific biases in detection of adduct-induced mutations. 
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Thus, a complete SHAPE-MaP experiment consists of three reactions: plus-reagent (+), minus-reagent 
(−), and denaturing control (DC). 
Mutational Profiling (MaP) 
After SHAPE modification of RNA, reverse transcriptase is used to create a mutational profile. 
This step encodes the positions and relative frequencies of SHAPE adducts as mutations in the cDNA 
sequence. Mutational profiling is efficient, with roughly 50% of SHAPE adducts detected as mutations in 
the cDNA (15). Whereas the reverse transcription reaction conditions are the same for any RNA, the 
researcher may choose one of two options regarding the type of DNA primer used. RNAs that are small 
enough to be sequenced end-to-end in a single massively parallel sequencing read (currently read lengths 
up to 600 nts are possible) can be subjected to reverse transcription with sequence-specific DNA primers. 
Specific primers can also be used when a specific sub-region of a large RNA is of interest (Fig. 2.2, small 
RNA and amplicon workflows). Use of gene- or region-specific primers also makes it possible to: (i) 
analyze a specific, relatively rare RNA in a complex mixture of RNAs or (ii) interrogate very rare, low 
abundance, RNAs. For analysis of large RNAs or the constituents of entire transcriptomes or multi-
component ribonucleoprotein and long noncoding RNA assemblies, random primers facilitate even 
coverage of complex RNA states in a single experiment (Fig. 2.2, randomer workflow). Following 
mutational profiling with appropriate primers, one of three workflows is used for library construction, as 
detailed below. 
Library construction and sequencing 
The Small RNA workflow is ideally suited for RNAs or sub-regions of large RNAs that are short 
enough to be completely sequenced by a single unpaired sequencing read or by two mated paired-end 
sequencing reads. After reverse transcription with sequence-specific primers, purified cDNA is “tagged” 
with incomplete platform-specific adapters in a limited-cycle PCR reaction. The resulting dsDNA product 
is purified and further amplified in a second PCR reaction that completes the platform-specific adapter 
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including sequence indices for sample multiplexing. After purification, sequencing libraries are of 
uniform size and each DNA molecule contains the entire sequence of interest (Fig. 2.3a). 
The amplicon workflow is well suited for large, low-abundance RNAs or sub-regions of larger 
RNAs that cannot be sequenced end-to-end by a single deep sequencing read. After reverse transcription, 
purified cDNA is amplified via PCR with sequence-specific primers. The resulting dsDNA is then 
enzymatically fragmented and tagged with platform-specific adaptors and multiplexing indices. 
Sequencing libraries constructed in this way are of variable size, with each molecule containing a 
fragment of the original amplicon (Fig. 2.3b). Typically, when the amplicon workflow is used to 
construct a sequencing library, reverse transcription is primed with sequence-specific primers. However, 
if the researcher wishes to generate a sequencing library for a specific region of an RNA that was 
previously reverse transcribed with random primers, the amplicon workflow allows for targeted “re-
construction” of libraries. 
The randomer workflow can be used to construct sequencing libraries when the RNA of interest 
is large (greater than ~500 nt) and reasonably pure; for example, in the case of a viral RNA genome. In 
addition, the randomer workflow also is appropriate for analysis of very complex systems including 
complete RNA transcriptomes. After reverse transcription with appropriate random primers, purified 
cDNA is converted to dsDNA and then enzymatically fragmented and tagged with platform-specific 
adapters and multiplexing indices. The resulting sequencing library is of variable size, and each molecule 
corresponds to a fragment of the original RNA (Fig. 2.3c). After construction of high-quality SHAPE-
MaP libraries by either of the approaches described here, the library is subjected to sequencing with a 
massively parallel sequencing instrument. The MaP approach is fully compatible with any platform with a 
high per-nucleotide calling accuracy. 
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Figure 2.3 Representative library size distributions as a function of workflow. (a) Bioanalyzer 
electropherogram of a TPP riboswitch library produced with the small RNA workflow. The small peak to 
the left of the major product is unconverted step 1 PCR product. (b) A library (solid line) constructed 
from a single amplicon (dashed line) via the amplicon workflow. The library contains some DNAs 
slightly larger than the original amplicon because platform-specific adaptors are added to near-full length 
fragments. (c) A library (solid line) constructed via the randomer workflow. The sizes of dsDNA 
produced by second-strand synthesis (dashed line) set the upper limit on the library size.  
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Results 
Small RNA workflow – TPP riboswitch 
A SHAPE profile for the aptamer domain of the TPP riboswitch was readily obtained using the 
small RNA workflow. Using these data, secondary structure modeling for this riboswitch RNA improved 
from a base pair prediction accuracy of 73%, obtained using a nearest-neighbor thermodynamic algorithm 
alone, to 96%, using SHAPE-directed modeling (15). Observed reactivities correspond closely to those 
expected based on the local nucleotide flexibilities for the ligand-bound RNA (Fig. 2.4a-c). Reactive 
nucleotides fall in conformationally flexible single-stranded regions, especially the L3 loop and the J2-4 
and J3-2 strands. Overall, relatively few nucleotides are reactive by SHAPE, consistent with the highly 
constrained conformation of this RNA. SHAPE-MaP also reveals fine differences corresponding to 
changes induced upon binding by the TPP ligand (Fig. 2.4b-d). Ligand interactions induce a large 
structural organization in the L5 loop and in the J3-2 elements in the ligand-binding pocket. 
Amplicon workflow – Mouse ribosomal RNA 
The utility of the amplicon workflow is two-fold: (i) it can be used to enrich for low-abundance 
RNAs and (ii) it allows for focused sequencing of a specific region of interest within a large RNA. As an 
example of this second use, primers targeting the Mus musculus 18S rRNA 3ʹ′ domain were used to 
generate SHAPE-MaP data for this region using the amplicon workflow. Even though the amplicon 
workflow introduces 20-30 additional cycles of PCR relative to traditional library preparations (e.g. the 
randomer workflow), SHAPE reactivity data are very similar between the two approaches. The amplicon 
approach retains information about the original RNA structure (Fig 2.5a) and, over 740 nucleotides of the 
mouse 18S rRNA, data from the amplicon and randomer workflows correlate strongly, with R = 0.85 
(Fig. 2.5b). Thus, the amplicon workflow is a viable and useful alternative to other enrichment or 




Figure 2.4 Example of results obtained with the small RNA workflow. (a) SHAPE profile of the TPP 
riboswitch produced using the small RNA workflow. (b) Difference SHAPE profile illustrating 
conformational changes induced in the TPP riboswitch upon ligand binding. (c) SHAPE-MaP reactivities 
superimposed on the structure (PDB: 2GDI) of the ligand-bound TPP riboswitch. Red, orange, and black 
correspond to high, moderate, and low reactivities, respectively, and correspond to reactivities shown in 
(a). (d) Visualization of ligand-induced conformational changes on the TPP riboswitch structure.  




Figure 2.5 Example of results obtained with the amplicon workflow. (a) SHAPE reactivity values 
plotted on the 3ʹ′ domain of the mouse 18S rRNA. Black, orange, and red colors correspond to low, 
medium, and high reactivities. High reactivities occur predominantly in single-stranded regions, 
indicating that SHAPE reactivities obtained via the amplicon workflow accurately retain structural 
information. (b) Correlation between reactivity values obtained by the amplicon and randomer workflows. 
These data represent 740 nucleotides of the 18S rRNA and correlate with R = 0.85, showing that there is 
little difference between the two workflows. 
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Randomer workflow – Bacterial ribosomal RNA 
Large RNAs like the bacterial small and large ribosomal subunit RNAs (16S and 23S, 
respectively) are readily examined by applying the randomer workflow to total E. coli RNA (Fig. 2.6). 
Using random primers, both RNAs can be studied simultaneously with fully automated analysis involving 
approximately 3 days of hands-on experimental effort. The major post-processing requirement is that the 
per-nucleotide hit level be sufficiently high to permit full recovery of the underlying SHAPE data. In 
general, the hit level should be 5 or greater, corresponding to a read depth of 1-2,000 (15). 
The 23S rRNA subunit alone represents ~2,900 nucleotides of SHAPE reactivity information 
after computational data processing (Fig. 2.6a). Comparing the SHAPE reactivities for domain IV of the 
23S rRNA with the accepted sequence covariation-derived structural model (Fig. 2.6b-c) shows good 
agreement. Regions involved in canonical base pairs have low SHAPE reactivity, indicating that they are 
structurally constrained. Conversely, single-stranded loop and bulge regions have high SHAPE reactivity, 
indicating structural flexibility. Because of the inherent scalability of the MaP approach, these data – 
spanning several thousand nucleotides – are as accurate at single-nucleotide resolution as are data from a 
short RNA, like the TPP riboswitch. 
Conclusion 
In sum, SHAPE-MaP yields quantitative nucleotide-resolution RNA structural information, 
accessible via one (or more) of several convenient experimental workflows. SHAPE data enable accurate 
secondary structure modeling, allow for the identification of well-determined regions within large RNAs, 
facilitate discovery of novel functional RNA motifs, make possible deconvolution of sequence 
polymorphisms in a single experiment, detect diverse effects of ligand and protein binding, readily allow 
analysis of low-abundance RNAs, and scale gracefully from short RNAs to transcriptome-wide analyses, 
including in cells. We anticipate that SHAPE-MaP will contribute to deep understandings of the 




Figure 2.6 Example of results obtained with the randomer workflow. (a) SHAPE reactivities across 
the entire E. coli 23S rRNA obtained in a single experiment. (b) Expanded view of SHAPE reactivities 
for Domain IV of the 23S rRNA. (c) Accepted secondary structure of Domain IV colored by SHAPE 
reactivity. Reactive nucleotides (orange and red) occur predominantly in single-stranded regions.  
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Methods 
SHAPE-MaP data for the TPP riboswitch and E. coli 16S rRNA were obtained previously (22) 
using the small RNA and randomer workflows, respectively. Data for the mouse 18S rRNA was obtained 
as described below. 
RNA extraction and modification 
To obtain SHAPE-MaP data for the mouse 18S rRNA, trophoblast stem cells (TSCs) were 
cultured as described (23). Approximately 106 TSCs were washed and pelleted in ice-cold PBS, 
resuspended in 2.5 ml Lysis Buffer [40 mM Tris, pH 7.9, 25 mM NaCl, 6 mM MgCl2, 1 mM CaCl2, 256 
mM sucrose, 0.5% Triton X-100, 1,000 U/ml RNasin (Promega), 450 U/ml DNase I (Roche)], and rotated 
at 4 °C for 5 minutes. Cells were then pelleted at 4 °C for 2 minutes at 2250 g, resuspended in 40 mM 
Tris pH 7.9, 200 mM NaCl, 1.5% SDS, and 500 μg/ml of Proteinase K, and rotated at 20 °C for 45 
minutes. RNA was then extracted twice with phenol:chloroform:isoamyl alcohol (24:24:1) pre-
equilibrated with 1× Folding Buffer (100 mM HEPES, pH 8.0, 100 mM NaCl, 10 mM MgCl2), followed 
by one extraction with chloroform. RNA was exchanged into 1.1× Folding Buffer using a desalting 
column (PD-10, GE Life Sciences) and incubated at 37 °C for 20 minutes. Approximately 3 μg RNA was 
then added to a one-ninth volume of 1M7 in neat DMSO (10 mM final concentration), and then incubated 
at 37 °C for 5 minutes. Modified RNA was purified (RNeasy Midi spin column, Qiagen) and eluted in 
approximately 50 μl H2O. No-reagent negative control RNA was prepared in the same way except that 
neat DMSO was substituted for SHAPE reagent. 
To prepare the denatured control, TSCs were grown as described (23), and total RNA was 
isolated using TRIzol (Ambion). Approximately 1.5 µg RNA was then resuspended in 150 µl 1.1× 
Denaturing Control Buffer [55 mM HEPES pH 8.0, 4.4 mM EDTA, 55% formamide (v/v)] and incubated 
at 95 °C for 1 minute. Aliquots of 45 µl of denatured RNA were then added to 5 µl of 100 mM 1M7, 
1M6, or NMIA, and allowed to react at 95 °C for 1 minute. After modification, RNA was purified 
(RNeasy Mini spin column, Qiagen) and eluted in approximately 50 μl H2O. 
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SHAPE-MaP 
Mutational profiling reverse transcription reactions were primed with 2 pmol of an rRNA-specific 
primer (5ʹ′-ACCATCCAATCGGTAGTAGC-3ʹ′) (22). The resulting cDNA was purified (G-50 spin 
column, GE Healthcare) and eluted in 50 µl H2O. cDNAs were then used as templates for for either by 
second strand synthesis (40 µl input, NEBNext Second Strand Synthesis Module, NEB) or PCR (0.5 µl 
input) with rRNA-specific primers (forward: 5ʹ′-GAGGTGAAATTCTTGGACCG-3ʹ′, reverse: 5ʹ′- 
ACCATCCAATCGGTAGTAGC-3ʹ′). PCR reactions were performed in 50 µl volumes (1× Q5 Reaction 
Buffer, 200 µM dNTPs, 0.5 µM each primer, 0.02 U/µl Q5 high-fidelity DNA polymerase) using a 
touchdown format: 98 °C for 30 s, 25 cycles of [98 °C for 10 s, 72 °C for 30 s (decreasing by 1 °C per 
cycle until 60 °C), 72 °C for 30 s], 72 °C for 2 min. The resulting dsDNA was purified (Agencourt XP 
beads, Beckman Coulter) before construction of high-throughput sequencing libraries (Nextera XT, 
Illumina). Libraries were purified (Agencourt XP beads, Beckman Coulter) prior to sequencing on an 
Illumina Miseq instrument, generating 2 × 250 paired-end reads. 
SHAPE profile generation 
Raw sequencing reads were quality-trimmed and aligned to the mouse 18S rRNA sequence 
(GenBank accession: NR_003278) using ShapeMapper (http://chem.unc.edu/rna/software.html). The 
resulting SHAPE reactivity profiles, corresponding to amplicon workflow and randomer workflow library 




1. P. A. Sharp, The Centrality of RNA. Cell. 136, 577–580 (2009). 
2. E. J. Merino, K. A. Wilkinson, J. L. Coughlan, K. M. Weeks, RNA structure analysis at single 
nucleotide resolution by selective 2'-hydroxyl acylation and primer extension (SHAPE). J. Am. 
Chem. Soc. 127, 4223–4231 (2005). 
3. C. M. Gherghe, Z. Shajani, K. A. Wilkinson, G. Varani, K. M. Weeks, Strong correlation between 
SHAPE chemistry and the generalized NMR order parameter (S2) in RNA. J. Am. Chem. Soc. 
130, 12244–12245 (2008). 
4. K. A. Wilkinson et al., Influence of nucleotide identity on ribose 2'-hydroxyl reactivity in RNA. 
RNA. 15, 1314–1321 (2009). 
5. J. L. McGinnis, J. A. Dunkle, J. H. D. Cate, K. M. Weeks, The mechanisms of RNA SHAPE 
chemistry. J. Am. Chem. Soc. 134, 6617–6624 (2012). 
6. K. A. Wilkinson et al., High-throughput SHAPE analysis reveals structures in HIV-1 genomic 
RNA strongly conserved across distinct biological states. PLoS Biol. 6, e96 (2008). 
7. C. Gherghe et al., Definition of a high-affinity Gag recognition structure mediating packaging of a 
retroviral RNA genome. Proc. Natl. Acad. Sci. U.S.A. 107, 19248–19253 (2010). 
8. E. J. Archer et al., Long-Range Architecture in a Viral RNA Genome. Biochemistry. 52, 3182–
3190 (2013). 
9. J. Tyrrell, J. L. McGinnis, K. M. Weeks, G. J. Pielak, The cellular environment stabilizes adenine 
riboswitch RNA structure. Biochemistry. 52, 8777–8785 (2013). 
10. J. L. McGinnis, K. M. Weeks, Ribosome RNA assembly intermediates visualized in living cells. 
Biochemistry. 53, 3237–3247 (2014). 
11. S. A. Mortimer, K. M. Weeks, A fast-acting reagent for accurate analysis of RNA secondary and 
tertiary structure by SHAPE chemistry. J. Am. Chem. Soc. 129, 4144–4145 (2007). 
12. K. E. Deigan, T. W. Li, D. H. Mathews, K. M. Weeks, Accurate SHAPE-directed RNA structure 
determination. Proc. Natl. Acad. Sci. U.S.A. 106, 97–102 (2009). 
13. C. E. Hajdin et al., Accurate SHAPE-directed RNA secondary structure modeling, including 
pseudoknots. Proc. Natl. Acad. Sci. U.S.A. 110, 5498–5503 (2013). 
14. G. M. Rice, C. W. Leonard, K. M. Weeks, RNA secondary structure modeling at consistent high 
accuracy using differential SHAPE. RNA. 20, 846–854 (2014). 
15. N. A. Siegfried, S. Busan, G. M. Rice, J. A. E. Nelson, K. M. Weeks, RNA motif discovery by 
SHAPE and mutational profiling (SHAPE-MaP). Nat. Methods. 11, 959–965 (2014). 
16. C. D. S. Duncan, K. M. Weeks, SHAPE Analysis of Long-Range Interactions Reveals Extensive 
and Thermodynamically Preferred Misfolding in a Fragile Group I Intron RNA. Biochemistry. 47, 
8504–8513 (2008). 
 36 
17. J. L. McGinnis, C. D. S. Duncan, K. M. Weeks, High-throughput SHAPE and hydroxyl radical 
analysis of RNA structure and ribonucleoprotein assembly. Meth. Enzymol. 468, 67–89 (2009). 
18. J. M. Watts et al., Architecture and secondary structure of an entire HIV-1 RNA genome. Nature. 
460, 711–716 (2009). 
19. R. C. Spitale et al., RNA SHAPE analysis in living cells. Nat. Chem. Biol. 9, 18–20 (2012). 
20. K.-A. Steen, G. M. Rice, K. M. Weeks, Fingerprinting noncanonical and tertiary RNA structures 
by differential SHAPE reactivity. J. Am. Chem. Soc. 134, 13160–13163 (2012). 
21. S. A. Mortimer, K. M. Weeks, Time-resolved RNA SHAPE chemistry. J. Am. Chem. Soc. 130, 
16178–16180 (2008). 
22. N. A. Siegfried, S. Busan, G. M. Rice, J. A. E. Nelson, K. M. Weeks, RNA motif discovery by 
SHAPE and mutational profiling (SHAPE-MaP). Nat. Methods. 11, 959–965 (2014). 
23. J. Quinn, T. Kunath, J. Rossant, in Placenta and Trophoblast (Humana Press, New Jersey, 2005), 




CHAPTER 3: DETECTION OF RNA-PROTEIN INTERACTIONS IN LIVING CELLS WITH 
SHAPE 
Introduction 
Nearly all RNAs, regardless of function, interact with one or more protein partners in order to 
function properly (1, 2). Characterizing ribonucleoprotein (RNP) complexes is thus an important step in 
understanding RNA function. Several well-validated approaches have been developed to explore RNP 
complexes (3). These methods provide many valuable insights but often have a limited scope due to 
affinity purification steps that require prior knowledge about the RNA or protein of interest. As RNA 
structure studies expand to 'omics scales, direct and accurate approaches for uncovering sites of 
interaction between the transcriptome and the proteome will become increasingly important. 
SHAPE-MaP (selective 2ʹ′-hydroxyl acylation analyzed by primer extension and mutational 
profiling) combines well-validated SHAPE RNA structure probing chemistry (4, 5) with massively-
parallel sequencing to enable high-throughput interrogation of RNA flexibility at single-nucleotide 
resolution (6, 7). When probed with SHAPE reagents, conformationally flexible nucleotides exhibit high 
reactivity. Conversely, nucleotides constrained by base pairing or by other interactions show low 
reactivities. The quantitative relationship between SHAPE reactivity and conformational flexibility is 
maintained even for nucleotides that are not solvent accessible as visualized in static RNPs (5), indicating 
that SHAPE can be used to probe the interiors of RNA-protein complexes.  Previous work has shown that 
SHAPE reagents readily modify RNAs in living cells (8-13). Finally, SHAPE-MaP uniquely allows for 
thorough and quantitative analysis of specific individual RNAs within the contents of an entire 
transcriptome with the use of targeted primers (6, 14). Thus, SHAPE-MaP offers a broadly useful strategy 
for probing the structure of the entire transcriptome, or elements thereof, under diverse experimental 
conditions. 
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A wide variety of RNA structure probing methods have been proposed (15, 16), most of which 
depend on accurately identifying and quantifying cDNA ends created when reverse transcriptase enzymes 
encounter a chemical adduct or cleavage site. These methods all involve a critical adapter-ligation step. In 
principle, these methods make it straightforward to perform RNA structure probing on the entire contents 
of a given transcriptome; in practice, it is currently almost impossible to perform the adapter-ligation step 
quantitatively (17, 18).  Moreover, transcriptome-wide experiments are strongly subject to the classic 
multiple and sparse measurement problems such that many measurements are unlikely to be statistically 
significant (6) and do not survive follow-up validation (19).  Thus, an important challenge in large-scale 
and in-cell RNA structure analyses is to robustly detect significant structural changes.  
We hypothesized that most RNA-protein interactions would affect the flexibility of nucleotides at 
the binding site and that by comparing SHAPE reactivities of deproteinized RNA (ex vivo) with 
reactivities obtained by probing RNA in living cells (in cellulo), it would be possible to characterize sites 
of RNP interactions (Fig. 3.1a). We developed an analysis framework that enables detection of RNP 
interactions based upon three principles: (i) RNA-protein interactions strongly affect SHAPE reactivity, 
either positively or negatively; (ii) due to measurement errors and the large number of reactivity 
measurements made, not all apparent reactivity changes are significant; and (iii) most RNA-protein 
interaction sites (20) will span sites of five or more nucleotides in primary sequence.  
To identify changes in SHAPE reactivity associated with protein interactions, we used the 
SHAPE reagent 1-methyl-7-nitroisatoic anhydride (1M7) to generate in cellulo and ex vivo SHAPE-MaP 
datasets for U1, 5S, and SRP RNAs (Fig. 3.1a). These RNAs enable evaluation of RNPs located both in 
the nucleus and in the cytoplasm and high-resolution structures of their complexes with proteins are 
available (21-26). Alternative SHAPE reagents have been proposed for in cellulo modification (8, 12). 
We compared 1M7 SHAPE-MaP with recently published in-cell SHAPE (icSHAPE), which uses a 
clickable RNA acylation reagent (NAI-N3) to allow enrichment of RNAs modified with this relatively 
weakly reactive reagent. We found that icSHAPE measurements show very low correlation with those 
 39 
 
Figure 3.1 Experimental and analytical framework for detecting SHAPE-MaP reactivity 
differences. (a) Total cellular RNA is treated with 1M7 under native conditions in living cells (top) or 
following non-denaturing extraction into folding buffer (bottom). RNAs that interact stably with cellular 
proteins (green) exhibit different SHAPE reactivities under in cellulo versus ex vivo conditions. Black, 
orange, and red illustrate low, moderate, and high reactivities, respectively on the secondary structure 
diagram and in SHAPE-MaP profiles. (b) Calculation of differences in SHAPE reactivities (ΔSHAPE) 
between experimental conditions A and B (upper left). If (i) the Z-factor for a nucleotide is greater than 
zero, indicating that the 95% confidence intervals of measurements in the two conditions do not overlap, 
(ii) the standard score is greater than one standard deviation from the mean ΔSHAPE (lower left), and 
(iii) three of five nucleotides in a sliding window meet both Z-factor and standard score criteria (lower 
right), the reactivity difference is accepted as significant.  
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obtained with SHAPE-MaP. Thus, we chose 1M7 for its short half-life, ability to accurately report RNA 
secondary structure ex vivo (4-7, 27) and in living cells (9-11), and because in-cell reactivity of 1M7 is 
sufficiently robust that downstream enrichment is not required. 
Differences in SHAPE reactivities (ΔSHAPE) were calculated by subtracting in cellulo SHAPE 
reactivities from ex vivo reactivities (Fig. 3.1b, upper left) and averaging over a three-nucleotide sliding 
window to reduce local signal fluctuation. By this definition, positive ΔSHAPE values indicate protection 
from modification in the cellular environment, and negative ΔSHAPE reports enhanced reactivity in cells. 
In a SHAPE-MaP experiment, discrete mutation events contribute to the overall reactivity at each 
nucleotide and are well modeled by a Poisson distribution (6). The standard error in the SHAPE reactivity 
measurement can therefore be estimated for every nucleotide (6). We used these error estimates to 
perform a modified Z-factor test (6, 28) for all positions in a given RNA (Fig. 3.1b, upper right). This test 
compares the magnitude of ΔSHAPE with the associated ex vivo and in cellulo measurement errors, 
identifying nucleotides for which the magnitudes of the errors are too large for the ΔSHAPE values to be 
significant. We formulated the Z-factor test such that the underlying ex vivo and in cellulo SHAPE 
reactivities must differ by more than 1.96 standard deviations (Z-factor > 0), ensuring that the 95% 
confidence intervals of each measurement do not overlap. 
For many nucleotides, SHAPE-MaP reactivity measurements have very small errors, allowing for 
the possibility that a trivially small ΔSHAPE could be considered significant according to the Z-factor 
test. We expected most stable protein-RNA interactions to have a strong effect on the reactivity of 
nucleotides at the binding site, so we calculated a standard score at each nucleotide to identify the largest 
ΔSHAPE values (Fig. 3.1b, lower left). This metric compares ΔSHAPE of a given nucleotide with the 
ΔSHAPE of all other nucleotides in the RNA, regardless of Z-factor. We required that the absolute value 
of each standard score be ≥ 1, meaning that individual ΔSHAPE values must be at least one standard 
deviation away from the mean ΔSHAPE. Thus, only the largest ΔSHAPE values are considered for 
further analysis. To determine final RNA-protein interaction sites, we filtered by Z-factor and standard 
score simultaneously (Fig. 3.1b, lower right). If, in a 5-nucleotide window, at least three nucleotides had 
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a Z-factor > 0 and an absolute standard score ≥ 1, those three (or more) nucleotides were considered to 
have significant cell-induced changes in SHAPE reactivity.  
In this work, we show that biochemical RNA structure probing data generated with the well-
validated SHAPE-MaP approach can be used to identify significant, meaningful changes in RNA 
structure between two states. Here, these states are the RNA in healthy mouse trophoblast stem cells and 
the same RNAs gently extracted from cells.  We validate our approach with the abundant and well-
characterized U1 small nuclear RNA (snRNA), 5S rRNA, and signal recognition particle (SRP) RNP 
complexes, illustrating that the statistical filters implemented in our analysis robustly identify sites of 
protein interactions. We then examine RNase MRP, an important RNP complex whose in-cell 
architecture is relatively poorly understood. Our analysis confirms several reported RNA-protein 
interactions within the complex, and also characterizes the underlying molecular phenotype of many 
disease-associated mutations. 
Results 
Comparison of SHAPE-MaP and icSHAPE 
We compared the similarity of RNA structure probing data for SHAPE-MaP and icSHAPE (12) 
experiments using the SRP RNP complex and six mRNAs. When probing SRP ex vivo, we found that 
strong icSHAPE signals are generally indicative of flexible nucleotides (Fig. 3.2a), as expected for 
SHAPE reagents. However, in comparison to SHAPE-MaP, the icSHAPE results appear roughly binary, 
with relatively few intermediate reactivity values. In comparing in cellulo data, SHAPE-MaP and 
icSHAPE data show very poor correlations. The differences between ex vivo and in cellulo icSHAPE 
values exhibit strong, punctate positive values throughout the RNA and dramatically strong negative 
values near the 5ʹ′ end (Fig. 3.2b). The icSHAPE data would suggest that the SRP RNA undergoes 
extreme and widespread conformational changes in cells, which is not consistent with prior work on this 
RNA (24, 25). Further in cellulo 
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Figure 3.2 Comparison of SHAPE-MaP and icSHAPE reactivities. (a) Ex vivo SHAPE reactivity of 
the mouse SRP RNA derived from SHAPE-MaP (black) and icSHAPE (red) (12). Many nucleotides with 
significant SHAPE-MaP reactivities are scored as unreactive by icSHAPE and, conversely, icSHAPE 
reports multiple nucleotides as reactive that have little or no reactivity by SHAPE-MaP. (b) In-cell 
SHAPE reactivity of SRP RNA, colored as in (a). Note the very high icSHAPE reactivities at the 5ʹ′ end 
of the RNA, which likely reflects long modification times, adaptor ligation, or both. (c) Plot of the “vitro–
vivo difference” (VTD) (12) for SRP RNA, in which the in-cell icSHAPE profile is subtracted from the ex 
vivo profile. The VTD profile exhibits strong, punctate positive values throughout the RNA and strong 
negative values near the 5ʹ′ end. These observations suggest that the SRP RNA undergoes extreme and 
large-scale conformational changes in cells, which is not consistent with accepted features of this RNA  
(24, 25). Grey shading indicates regions for which no icSHAPE values were generated.  
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between icSHAPE and SHAPE-MaP was consistently poor, with correlation coefficients ranging from 
0.1-0.3. 
Validation of the ΔSHAPE approach 
We used SHAPE-MaP to analyze three model RNAs ex vivo and in cellulo. The U1 snRNA is 
localized in the nucleus and forms the U1 snRNP complex upon binding several proteins: U1A, U1C, U1-
70K, and the heteroheptameric Sm ring. Comparison of U1 snRNA ex vivo and in cellulo SHAPE 
reactivities revealed distinct qualitative reactivity differences throughout the RNA (Fig. 3.3a). Due to 
differences in the number of individual mutation events observed relative to the times a given nucleotide 
was sequenced, the estimated errors vary as a function of nucleotide position and are much greater for 
some reactivity measurements than others. This is a feature shared by all RNA structure probing 
experiments read out by massively parallel sequencing but is explicitly and uniquely measured using the 
MaP strategy. If a naïve approach had been taken that ignored these errors, multiple regions would have 
been (incorrectly) identified as having significant SHAPE reactivity differences (Fig. 3.3b, grey and 
green shading). Only a subset of these regions are involved in true RNA-protein interactions; the 
remainder are analysis artifacts caused by the measurement uncertainties that occur in any experiment, 
especially those read out by massively parallel sequencing. When we applied the complete analysis 
framework in which the Z-factor test is used to account for these errors, only three regions of significant 
ΔSHAPE were identified (Fig. 3.3b, green shading only). The locations of these positive ΔSHAPE 
values correspond precisely to known interactions sites of U1-70K, U1A, and the Sm ring proteins 
(Fig. 3.3c). 
We next examined the differences in reactivities of the SRP RNA ex vivo versus in cellulo 
(Fig. 3.4a). The SRP RNA associates with six proteins and is comprised of an Alu domain at the 5ʹ′ end 
connected by a long central helix to the S domain. The Alu domain is bound by the SRP9-SRP14 
(SRP9/14) heterodimer, and the larger S domain interacts with SRP19, SRP54, and the SRP68-SRP72 
(SRP68/72) heterodimer. The SHAPE reactivity changes identified by our analysis were largely localized
  
Figure 3.3 Identification of protein binding sites by ΔSHAPE analysis. (a) Smoothed SHAPE 
reactivities for U1 snRNA in cellulo (blue) and ex vivo (red). (b) ΔSHAPE values for the U1 snRNA. 
Significant reactivity changes established by the ΔSHAPE analysis framework are shaded green. If 
measurement errors were not taken into account, several off-target interaction sites would have been 
incorrectly identified as significant (grey shading). Primer-binding regions for which no data are available 
are shown with dashed lines. (c) Model of the human U1 snRNA complex including U1-70K (orange), 
U1-C (red), U1A (blue), and Sm ring proteins (purple; subunit D1 excluded for clarity). RNA is shown as 
a ribbon. Nucleotides that exhibit significant ΔSHAPE values are emphasized as spheres.  
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Figure 3.4 Summary of results obtained for the SRP RNA. (a) ΔSHAPE profile for the entire SRP 
RNA. In cellulo protections are shaded green, and in cellulo reactivity enhancements are purple. 
Locations of the Alu and S domains are indicated. (b) Crystal structure of the Alu domain bound to 
SRP9/14. Nucleotides with significant reactivity differences are labeled. (c) Model of the S domain bound 
to SRP68, SRP19 and SRP54 with significant reactivity differences indicated. 
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to these two domains, consistent with a lack of protein binding in the central helix.  
In the Alu domain, we observed in cellulo protection at the SRP9/14 binding site (nts 24-26). We 
also detected enhanced in cellulo reactivity at nucleotides 35-37 and 46-48, consistent with protein-
induced tertiary structure changes (Fig. 3.4b). In the S domain, we observed extensive in cellulo 
protection where SRP19 and SRP54 bind (Fig. 3.4c). Binding by SRP68/72 involves insertion of an α–
helix into the major groove of the central helix, causing an adjacent asymmetric internal loop to open 
(24). Consistent with this observation, we detect enhanced in cellulo reactivity on the opened side of this 
loop at positions 230-232 (Fig. 3.4c). The interaction between SRP RNA and the complete SRP68/72 
heterodimer has not been characterized at high resolution; however, cryo-electron microscopy data 
provide evidence that a portion of SRP68/72 interacts with the central helix at an internal “hinge” loop 
comprised of nucleotides 97-104 and 249-253 (25). In-cell SHAPE supports this observation, as enhanced 
in cellulo reactivity was noted on both sides of the loop at nucleotides 99-101 and 251-253, and suggests 
a local conformational change also occurs at nucleotides 230-232. Overall, every region of significant in 
cellulo protection in the SRP RNA identified by our analysis framework corresponds to sites of direct 
protein binding. 
In examining the 5S rRNA, which forms a complex with ribosomal protein L5, we detected 
several regions of in cellulo protection (Fig. 3.5a). These sites correspond to previously identified 
contacts between 5S rRNA and L5 (Fig. 3.5b) (8, 29). There were no other sites with significant 
ΔSHAPE values, although many ribosomal proteins are known to be located near the 5S particle in fully 
assembled ribosomes. These results are consistent with the observations that a significant fraction of 
cellular 5S RNPs are not ribosome-associated (30) and that 5S rRNA adopts multiple conformations even 
when associated with the ribosome (31). We infer that ∆SHAPE analysis primarily detects only the stable 
protein-RNA interactions in the 5S rRNA, and that these involve L5. 
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Figure 3.5 Summary of results obtained for the 5S rRNA. (a) ΔSHAPE profile of 5S rRNA with 
nucleotides protected in cellulo indicated in green. (b) Cryo-EM structure (26) of the 5S rRNA bound to 
ribosomal protein L5. Sites of significant ΔSHAPE are labeled. 
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Application of ΔSHAPE to RNase MRP 
We next applied the ΔSHAPE analysis framework to in-cell analysis of the RNA component of 
mouse RNase MRP (RMRP). This RNA forms a complex with 10 proteins in eukaryotes that functions in 
rRNA processing and mitochondrial replication (32). In humans, numerous mutations within RMRP RNA 
cause a spectrum of autosomal recessive skeletal diseases ranging from cartilage-hair hypoplasia (CHH) 
to anauxetic dysplasia (AD) (33). The structure of and protein interactions with the RNA component of 
RMRP have been investigated in vitro using affinity selection, chemical probing, and crosslinking 
experiments (32, 34-36). A recent cryo-EM study has revealed the overall three-dimensional architecture 
of the complex in yeast (37). However, the precise binding sites of proteins and interactions with 
substrate have not been examined natively in cells. 
Multiple regions of the RMRP RNA have statistically significant enhanced reactivity or 
protection in cellulo (Fig. 3.6a) and many of these can be attributed to interaction with protein 
components. These include in the P3 domain, a functionally critical element (Fig. 3.6b) (38), as well as 
nucleotides near the junction of helices P8, P9, and P12. Cryo-EM data suggest this latter region interacts 
with protein Pop4 and perhaps additional proteins (Fig. 3.6c). We also observed enhanced reactivity at 
internal loops in helix P12. Although the complete P12 helix is not present in the cryo-EM model, its 
proximity to the Pop3 protein suggests that the reactivity enhancements located in the P12 helix may be 
due to conformational changes induced by Pop3. 
We also observed protections involving helices P2 and P19 that are not attributable to RNA-
protein interactions. In the cryo-EM model of RMRP, these two regions are adjacent to the active site and 
are oriented such that they may stabilize or direct RMRP substrates to the catalytic center (Fig. 3.6d). 
Additional density in the cryo-EM map adjacent to these sites of protection may reflect RMRP substrates 
co-purified with the complex, and supports the hypothesis that P2 and P19 play roles in substrate 
recognition. There is notable overlap between ΔSHAPE-detected protection in P2 and P19 and sites of 




Figure 3.6 In-cell analysis of RNase MRP RNA interactions. (a) Secondary structure of the RNA 
component of RMRP (40), showing RNA-protein interactions detected by ΔSHAPE analysis. Nucleotides 
protected in cellulo are shaded green, and those with enhanced reactivity are purple. Nucleotide positions 
corresponding to disease-associated mutations that affect function due to inferred (based on ∆SHAPE 
analysis) RNA structure, protein interactions, or catalysis and substrate recognition are shown in blue, 
red, and yellow, respectively. (b) Crystal structure of eukaryotic Pop6 (orange) and Pop7 (yellow) 
proteins interacting with the P3 domain of RMRP (PDB 3IAB). Nucleotides 31-37 demonstrate ΔSHAPE 
protection in cellulo (green spheres) and interact tightly with Pop7. Nucleotides on the opposite side of 
the P3 internal loop are not tightly associated with Pop6/Pop7 and, correspondingly, do not exhibit strong 
interactions as assessed by ΔSHAPE. (c) Model of the junction between RMRP RNA helices P8, P9, and 
P12, showing interactions with Pop4 (tan). Nucleotides exhibiting significant ΔSHAPE values are shown 
as spheres and colored as in panel (a). In the cryo-EM model, yeast Rpr2 (a potential homolog of Snm1) 
also binds in this region (37) and this protein or an alternative mouse protein may interact with 
nucleotides 82-84, 195-199, and 201-203. (d) Model of core regions in the eukaryotic RNase P RNP, 
showing regions of protection and enhanced reactivity as in (a-c). Conserved active site nucleotides are 
colored red. Nucleotides 217-220 and 239-245 are protected in cellulo and form a path to the active site, 
supporting a role in substrate recognition.  
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active site cleft suggests that this RNP enzyme is saturated with its RNA substrates (32) in the cellular 
steady state. 
Discussion 
Our experiments with the well-characterized U1, SRP, and 5S RNPs validate the ability of the 
ΔSHAPE analytical framework (Fig. 3.1), enabled by SHAPE-MaP, to correctly and specifically identify 
regions of RNA protected by stably-associated proteins in cellulo, even in the context of a large number 
of individual measurements and variable level of confidence in each.  In addition, this work illustrates the 
robust ability of the well-validated 1M7 reagent to react with RNP complexes located in both cytoplasmic 
and nuclear compartments in cells. 
In comparing SHAPE-MaP with icSHAPE, we found poor agreement between the two 
approaches. SHAPE-MaP has previously been extensively validated against a large set of RNAs with 
complex structures (6), suggesting that icSHAPE does not provide a robust view of RNA structure ex vivo 
or in cellulo (Fig. 3.2). icSHAPE also reports that the SRP RNA undergoes extensive internal 
conformational changes in cells, which is not consistent with prior studies of this RNA (24, 25).  
icSHAPE differs from SHAPE-MaP in important ways. First, NAI-N3 reacts more slowly than 1M7 (t1/2 
= ~30 min vs. ~17 sec, respectively), which has important consequences. These include, first, that slow 
(but not faster) reagents are highly sensitive to specific ion and buffer choices (41) making it very 
difficult to compare in-cell and ex vivo experiments and, second, that long reaction times will reflect RNP 
assembly and disassembly, cellular turnover, and other events unrelated to the steady-state structure of an 
RNA. icSHAPE is also one of the many proposed strategies that require a complex purification procedure 
followed by multi-step adapter ligation-based sequencing library construction, steps that are difficult to 
perform quantitatively (17, 18).  
In addition to defining in-cell RNA-protein and RNA-substrate interactions, ΔSHAPE analysis 
makes it possible to categorize disease-associated mutations in terms of their likely phenotypic effects 
(Fig. 3.6a). Our analysis supports the interpretation that most mutations leading to CHH/AD spectrum 
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diseases in the RNase MRP complex result from misfolding of the RNA secondary or tertiary structure, as 
they are not located near protein or substrate interaction sites. These structural changes occur in helices 
P1, P3, P4, P9, and P12 (Fig. 3.6a, blue nucleotides). We also identified a subset of CHH/AD-related 
mutations located near protein interaction sites (Fig. 3.6a, in red). In individuals with these mutations, 
which are most concentrated within helix P8 and the P8-P9-P12 junction, improper assembly of the 
RNase MRP RNA-protein complex may be the root cause of disease. Finally, the remaining disease-
related mutations are most consistent with compromising RNA-substrate interactions. These involve 
nucleotides that comprise the active site along with portions of P2 and P19 that are protected in cellulo 
due to putative substrate interactions (Fig. 3.6a, yellow). 
The ΔSHAPE analysis framework is clearly a broadly useful tool for defining RNA-protein 
interactions. ∆SHAPE is also subject to limitations. Because ΔSHAPE requires a change in SHAPE 
reactivity between conditions, proteins that interact primarily with double-stranded RNA may be difficult 
to detect. For the RNAs studied here, in-cell protections almost always corresponded to direct protein-
RNA interactions, while enhancements generally reported RNA conformational changes.  In other cases, 
protein-induced conformational changes may lead to apparent protections in regions unrelated to protein 
binding. While the ∆SHAPE framework correctly identified sites of stable RNA-protein interaction, the 
stringency implemented here may lead to missing weaker protein binding sites. For example, nucleotides 
stably bound by Sm ring proteins are detected by ΔSHAPE (Fig. 3.3) but other nucleotides inside the Sm 
ring do not display protection. Finally, as with any chemical probing experiment, ΔSHAPE requires 
sufficient sequencing coverage of the RNA of interest in both tested conditions. 
In sum, SHAPE-MaP efficiently and accurately detects RNA-protein interaction sites and 
occupancy in living cells. Using simple and intuitive statistical filtering, significant differences between 
ex vivo and in cellulo SHAPE reactivities were identified while avoiding false positive detection. The 
analysis framework developed here identified RNA binding sites for all stably bound protein factors for 
three model RNPs, found in both cytoplasmic and nuclear compartments, under native growth conditions 
without the need for specialized affinity purification. Application to the RNase MRP ribonucleoprotein 
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enzyme complex both identified sites of RNA-protein interaction and extensive substrate recognition in 
the active site cleft, and also enabled categorization of CHH/AD-related mutations by molecular 
phenotype.  
This analysis framework works well for de novo identification of functionally essential regions in 
non-coding RNAs, and is complementary to RNA-protein crosslinking and immunoprecipitation (CLIP)3 
experiments. Critically, ∆SHAPE specifically detects the occupancy of a given site.  As RNA structure 
studies increasingly shift towards in-cell and transcriptome-wide analyses, the robust analytical approach 
presented here will become an essential tool for rapid discovery and analysis of true RNA-protein 
interactions. 
Methods 
In cellulo modification 
Mouse trophoblast stem cells (TSCs) were cultured as described (42). Live TSCs were washed 
once with PBS, and 900 µl of fresh growth media was added. For samples subjected to in-cell SHAPE 
probing, 100 µl of 100 mM 1M7 in neat DMSO (10 mM final concentration) were added and rapidly 
mixed by swirling the culture dish. Cells were then incubated at 37 °C for 5 minutes (although the 1M7 
reagent is completely quenched by hydrolysis in ~2 minutes). Media was removed and the cells were 
washed once with PBS before isolation of total RNA (1 mL TRIzol; Ambion). The no-reagent negative 
control RNA was prepared similarly with the exception that neat DMSO was used instead of 1M7 in 
DMSO. 
Ex vivo RNA extraction and modification 
To preserve native secondary structures, RNA for ex vivo analysis was extracted using a gentle 
procedure, avoiding the use of harsh chemical denaturants. Approximately 106 TSCs were washed and 
pelleted in ice-cold PBS, resuspended in 2.5 ml Lysis Buffer [40 mM Tris, pH 7.9, 25 mM NaCl, 6 mM 
MgCl2, 1 mM CaCl2, 256 mM sucrose, 0.5% Triton X-100, 1,000 U/ml RNasin (Promega), 450 U/ml 
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DNase I (Roche)], and rotated at 4 °C for 5 minutes.  Cells were then pelleted at 4 °C for 2 minutes at 
2250 g, resuspended in 40 mM Tris pH 7.9, 200 mM NaCl, 1.5% SDS, and 500 μg/ml of Proteinase K, 
and rotated at 20 °C for 45 minutes. RNA was then extracted twice with phenol:chloroform:isoamyl 
alcohol (24:24:1) pre-equilibrated with 1× Folding Buffer (100 mM HEPES, pH 8.0, 100 mM NaCl, 10 
mM MgCl2), followed by one extraction with chloroform. Note that use of TRIzol and similar reagents 
should be specifically avoided for native-like purification of RNA. RNA was exchanged into 1.1× 
Folding Buffer using a desalting column (PD-10, GE Life Sciences) and incubated at 37 °C for 20 
minutes. Approximately 3 µg RNA was then added to a one-ninth volume of 100 mM 1M7 in neat 
DMSO (10 mM final concentration) and incubated at 37 °C for 5 minutes. Modified RNA was purified 
(RNeasy Midi spin column, Qiagen) and eluted in approximately 50 µl H2O. No-reagent negative control 
RNA was prepared in the same way but substituting neat DMSO for 1M7. 
Denaturing control 
TSCs were grown as described (42) and total RNA isolated using TRIzol (Ambion). 
Approximately 500 ng RNA was then resuspended in 1.1× Denaturing Control Buffer [55 mM HEPES 
pH 8.0, 4.4 mM EDTA, 55% formamide (v/v)] and incubated at 95 °C for 1 minute. An aliquot of 45 µl 
of denatured RNA was added to 5 µl of 100 mM 1M7 and allowed to react at 95 °C for 1 minute. After 
modification, RNA was purified (RNeasy Mini spin column, Qiagen) and eluted in approximately 50 µl 
H2O. 
U1, SRP, and 5S SHAPE-MaP 
Mutational profiling reverse transcription reactions were carried out using RNA-specific primers  
(6, 14), which maximizes efficient use of sequencing reads. cDNA was purified using G-50 spin columns 
(GE Life Sciences). SHAPE-MaP sequencing libraries were created for each experimental condition (ex 
vivo +1M7, ex vivo DMSO, in cellulo +1M7, in cellulo DMSO, denaturing control +1M7) and RNA (U1 
snRNA, 5S rRNA, SRP RNA) using the targeted specific-RNA approach (6) with minor changes. PCR 1 
followed the touchdown format (43) and was performed as follows: 98 °C for 30 s, 20 cycles of [98 °C 
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for 10 s, 72 °C for 30 s (decreasing by 1 °C per cycle until 64 °C), 72 °C for 20 s], 72 °C for 2 min. PCR 
2 was performed for 10 cycles using 2 µl unpurified PCR 1 product as template in a 50 µl reaction. Final 
libraries were then purified (PureLink PCR Micro spin columns; Life Technologies) prior to sequencing.  
Whole-transcriptome SHAPE-MaP 
Total RNA was modified as described above and then depleted of ribosomal RNA (mouse 
RiboZero; Epicentre). Mutational profiling reverse transcription reactions were primed with random DNA 
nonamers (6, 14). cDNA was purified (Agencourt RNAClean XP beads, Beckman Coulter) and then 
converted to double-stranded DNA (NEBNext mRNA second-strand synthesis kit, New England 
Biolabs). The resulting DNA was purified (Ampure XP beads, Beckman Coulter) before construction of 
whole-transcriptome sequencing libraries (Nextera XT, Illumina).  
Sequencing and SHAPE profile generation 
Purified U1, 5S, SRP, or whole-transcriptome sequencing libraries were sequenced on an 
Illumina MiSeq (U1, 5S, and SRP) or NextSeq (transcriptome) instrument, generating 2 × 150 paired-end 
datasets. Initial SHAPE reactivity profiles, including error estimates, were created by aligning reads to U1 
snRNA, 5S rRNA, SRP or RNase MRP RNA reference sequences (GenBank accession no. FM991912.1, 
M31319.1, HG323689.1, and NR_001460.1, respectively) using ShapeMapper (v1.0, 
http://chem.unc.edu/rna/software.html) (6, 14). Median per-nucleotide read depth was greater than 10,000 
for each of these RNAs. 
From transcriptome-wide datasets, we identified the 50 most abundant transcripts using Tophat 
(44). SHAPE reactivity profiles were then generated for each of these RNAs by aligning to respective 
sequences with ShapeMapper. Transcripts with complete sequencing coverage and sufficient depth 
(median read depth > 5,000) were selected for comparison to icSHAPE profiles. 
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SHAPE reactivity normalization 
SHAPE-MaP quantifies adduct formation based on the observed mutation rates of modified RNA 
relative to no-reagent and denaturing controls (6). We observed higher mutation rates in ex vivo-modified 
U1 snRNA than in the 5S and SRP RNAs. As a result, the SHAPE reactivities of U1 snRNA were 
generally elevated compared to the other RNAs. Independent normalization of U1 snRNA did not 
preserve the intrinsically high reactivity of this RNA relative to 5S and SRP. Thus, we normalized 
SHAPE reactivities with a common normalization factor to preserve the relative distribution of 
reactivities among the three simultaneously probed RNAs. RNase MRP SHAPE profiles were normalized 
independently, as they were derived from RNA probed separately from the three model RNAs. Initial 
SHAPE reactivities for both in cellulo and ex vivo-modified RNAs were first pooled together into a single 
distribution from which primer-binding sites were excluded. The first five nucleotides synthesized during 
reverse transcription were also excluded to eliminate spurious mutations caused by the suboptimal 
processivity of initiating retroviral reverse transcriptase (45). A normalization factor for the entire 
distribution was calculated by the boxplot method (27): the interquartile range (IQR) of the distribution 
was calculated; and reactivity values greater than 1.5 times the IQR were excluded as outliers with the 
number of outliers capped at 10%. The average of the 10% most reactive remaining nucleotides was then 
calculated, yielding the common normalization factor. Initial individual SHAPE profiles were then 
adjusted by dividing each reactivity and standard error by the common normalization factor. 
icSHAPE profile generation 
icSHAPE reads (12) were downloaded from the gene expression omnibus 
(http://www.ncbi.nlm.nih.gov/geo, accession GSE60034). Reads corresponding to U1 snRNA, 5S rRNA, 
SRP and RNase MRP RNA were extracted by alignment to the respective sequence. Relevant reads were 
then converted to fastq format and analyzed using the published icSHAPE pipeline 
(https://github.com/qczhang/icSHAPE) (12). Limited reads for U1 snRNA, 5S rRNA, and RNase MRP 
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RNA resulted in icSHAPE profiles with very sparse data, so we restricted our comparison of RNP 
complexes to the SRP RNA. 
Calculating ΔSHAPE, Z-factors, and standard scores to determine binding sites 
The derivation of nucleotide-resolution standard error values associated with SHAPE reactivity 
measurements has been described fully (6), and is reviewed briefly here. Mutation rates for each 
experimental measurement (+1M7, no-reagent, denaturing control) are modeled as a Poisson distribution 
because discrete mutation events contribute to the overall reactivity at each nucleotide. The variance of a 
Poisson distribution equals the number of observations, and the standard error of a mutation rate (SErate) 
can be estimated as 
SErate =    λreads = ratereads  (1) 
where λ is the number of mutations observed, reads is the read depth at a given nucleotide, and rate is the 
number of mutation events per read. The standard errors from each experimental measurement are then 
combined to yield SHAPE reactivity standard errors (6). 
The change in SHAPE reactivity (ΔSHAPE) for each nucleotide i was calculated as  
ΔSHAPEi =   13 Xn!!!!!!–! − Cn
!!!
!!!–!   (2) 
where X and C are the ex vivo and in cellulo SHAPE reactivities, respectively. This produces ΔSHAPE 
values that reflect the difference in reactivity between ex vivo and in cellulo conditions averaged over a 
three-nucleotide sliding window. To account for smoothing, standard error values were averaged as 
SEi =   13 𝜎!!!! + 𝜎!! + 𝜎!!!!   (3) 
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where σi and SEi refer to the original error and smoothed error at nucleotide i, respectively. Z-factors (Z) 
(28) for each nucleotide i were calculated according to Eqn. 4, where the subscripts X and C indicate ex 
vivo and in cellulo conditions, respectively. Nucleotides for which Z > 0 were considered to undergo 
significant changes in SHAPE reactivity. 
Zi = 1 − 1.96 SEX,i + SEC,i∆SHAPEi   (4) 
Standard scores (S) were calculated for each nucleotide i according to Eqn. 5, where µΔSHAPE and 
σΔSHAPE represent the mean and standard deviation of the distribution of ΔSHAPE values, respectively. 
Si = ∆SHAPEi − μ∆SHAPEσ∆SHAPE   (5) 
Putative binding sites were identified as regions within five-nucleotide sliding windows for which 
at least three nucleotides had Z > 0 and |S| ≥ 1. Nucleotides that met these requirements were denoted as 
undergoing changes in SHAPE reactivity due to the influence of the cellular environment. 
Modeling 
The model of the complete U1 snRNP complex used in this study was generated from three individual 
models. Phosphorus atoms in a U1 snRNP model (omitting stem-loop 2 and the U1A protein and kindly 
provided by Kiyoshi Nagai) were first aligned to the phosphorus atoms in a 5.5-Å model of the complete 
complex (PDB: 3PGW) (23). To incorporate the U1A/stem-loop 2 interaction, we aligned the Cα atoms 
of U1A in a high-resolution model (PDB: 4PKD) (46) to the 5.5-Å model. The model of the SRP S 
domain bound to SRP68/72, SRP19, and SRP54 was generated by overlaying the SRP68- and SRP19-
bound structure (PDB: 4P3E) (24) with the SRP19- and SRP54-bound structure (PDB: 1MFQ) (22) via 
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CHAPTER 4: SHAPE ANALYSIS REVEALS TRANSCRIPT-WIDE CELLULAR 
INTERACTIONS AND STABLE STRUCTURAL DOMAINS WITHIN THE XIST lncRNA 
Introduction 
Long noncoding RNAs (lncRNAs) play central roles in the regulation of gene expression through 
interactions with numerous protein partners (1, 2). Several lncRNAs are necessary for normal 
development (3, 4), and, as a result, their dysfunction is associated with diseases including cancer (5). 
Many more unstudied lncRNAs are located in disease-associated regions of the human genome, 
suggesting additional physiologically relevant examples of lncRNA-mediated gene regulation remain to 
be discovered (6-9).  Despite the importance of lncRNAs and their cellular interactions, little is known 
about how lncRNA structure mediates function. Here we use quantitative in-cell and ex vivo nucleotide-
resolution structure probing (SHAPE-MaP) to show that the X-inactive specific transcript (Xist) lncRNA 
forms multiple well-defined secondary structures with complexities comparable to those found in 
prominent viral RNAs, ribosomal RNA domains, and other regulatory RNAs. Nucleotide polymorphisms 
occur predominantly in predicted single-stranded regions, suggesting selective pressure maintains 
structured elements within the lncRNA. In contrast, repeated elements within Xist, which are common 
among lncRNAs (10), are distinctive in that they adopt dynamic structures with single-stranded regions 
that may function as landing pads for protein cofactors. Differences in chemical reactivity of the Xist 
lncRNA both in living cells and ex vivo suggest that the RNA binds proteins throughout its length and 
that some domains have dramatically different structures in cells. We identified a previously unknown 
interaction domain that bound numerous proteins and discovered examples of how lncRNA structure 
modulates specific protein interactions. Roughly half of the Xist RNA contains domains that either bind 
proteins or form well-defined structural elements, and these motifs span nearly the entire ~18 kilobase 
RNA, which rationalizes the conserved length of Xist among mammals.  Our results create a framework 
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for further investigation of Xist and, more broadly, establish an experimental context for understanding 
complex relationships between lncRNA sequence, structure, and function. 
Although it is clear that lncRNAs regulate gene expression at transcriptional, post-transcriptional 
and epigenetic levels, there are many unanswered questions about lncRNAs: Why are they so long? Are 
regulatory functions organized within these long RNAs? Do lncRNAs have well-defined structures? If so, 
to what extent does the cellular environment modulate structure? What are the specific structural features 
of the conserved repeat regions often found in lncRNAs? What features govern protein interactions? We 
sought to answer these questions as they pertain to the Xist lncRNA. 
Xist plays a central role in X-chromosome inactivation (XCI) during female eutherian mammalian 
development and is an archetype of gene-silencing lncRNAs. During the initiation of XCI, Xist spreads in 
cis along the future inactive X chromosome and recruits protein complexes, which in turn apply 
repressive chromatin markers to induce silencing (11, 12). Despite its discovery more than 20 years ago 
(13, 14), the sequence elements within Xist that contribute to its distinct function, and the mechanisms by 
which they do so, remain poorly defined. Xist is approximately 18 kilobases long, a length that is 
generally conserved (13-15); however, the primary sequence is less conserved than might be expected for 
an RNA of such importance. Several tandem repeat regions (labeled A-F in the mouse) exhibit moderate 
conservation (13-15), and at least two of these, Repeat A and the rodent-specific repeat C, have been 
implicated in silencing and localization to the inactive X, respectively (16-21). An additional 1.5 kilobase 
region encompassing repeats F and B has been shown to be required for the proper accumulation of 
heterochromatic marks over the inactive X (22). Beyond these three regions, the locations of additional 
functional domains within Xist are largely unexplored.  
A roadblock to understanding the mechanisms by which Xist carries out its cellular function has 
been our near-complete lack of knowledge of the structures it adopts as a free RNA and in cells. Detailed 
structural maps of other functional RNAs, such as the ribosomal RNAs (23) and the HIV RNA genome 
(24-26), have been fundamental to understanding the mechanisms by which individual domains within 
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large RNAs execute discrete cellular functions. A structural map of Xist would be expected to have a 
similar transformative impact. 
Selective 2'-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-
MaP) (25, 27) is a recently developed chemical strategy to analyze RNA structure that can be applied to 
any RNA regardless of its length. SHAPE-MaP provides a biophysically rigorous measurement of local 
nucleotide flexibility that is independent of base identity (25, 28, 29). SHAPE-MaP is sensitive enough to 
detect modifications in highly complex environments, including in the cell nucleus (30) and, unlike most 
RNA-probing methods with deep sequencing readout, is unaffected by biases introduced during ligation-
based library preparation steps. SHAPE data are sufficient to distinguish between different structural 
models (31) and can detect various modes of protein binding in cells (30). SHAPE has been used 
extensively in recent years to characterize the structural properties of long RNAs (24, 25, 32). SHAPE-
informed structural models have invariably yielded rich insights into the biological functions of diverse 
RNAs (24, 25, 31-34), and in many cases, uncovered novel functional elements (24, 25, 30, 34, 35). 
Using SHAPE-MaP, we examined full-length, authentic transcripts of mouse Xist at single-
nucleotide resolution under protein-free conditions (ex vivo) and natively in mouse trophoblast stem cells 
(TSCs). These cells show prototypical epigenetic patterns over the inactive X chromosome (36-38) and 
depend on Xist for its continued silencing (39, 40). The SHAPE data identified upwards of 30 regions in 
Xist that form complex, well-defined structures that resemble functional elements in viral and other 
RNAs (25, 27, 32). By comparison of ex vivo reactivities to those obtained in living TSCs, we found that 
large portions of Xist are bound by proteins and have different conformations in vivo, and found several 
domains in the 3ʹ′ half of Xist that appear to function as protein interaction platforms. Our data provide 
fresh insight into the mechanisms of Xist-mediated silencing and provide a broad structural foundation for 
understanding complex relationships between lncRNA sequence and function. 
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Results 
Ex vivo structure probing 
We first probed full-length Xist after gentle extraction and deproteination using the SHAPE 
reagents 1-methyl-7-nitroisatoic anhydride (1M7), 1-methyl-6-nitroisatoic anhydride (1M6), and N-
methyl-isatoic anhydride (NMIA) (41, 42) to obtain ex vivo SHAPE reactivities for 86% of all nucleotides 
in the Xist RNA (Fig. 4.1a). Due to the highly repetitive nature of repeats B and C, it is not possible to 
uniquely align sequencing reads to these regions, and we excluded them from our analysis (see Methods). 
We first searched for pseudoknots in the sequence guided by 1M7 reactivity data (43) and identified 10 
potential pseudoknots. Incorporating these, along with data from all three SHAPE experiments, we 
modeled the secondary structure of Xist using the well-validated three-reagent differential SHAPE 
approach (27, 44). We also modeled the structure without any SHAPE data and with only 1M7 data. As 
expected, data-driven SHAPE models are drastically different from the model generated without 
experimental data: the 1M7-only and differential models are only 49% and 46% similar to the no-data 
model, respectively. 
In an independent assessment of our models, we examined the structural context of 105 known 
single-nucleotide polymorphisms (SNPs) within mouse Xist. Given the critical and conserved functions of 
Xist, and the presumed importance of structural elements within the RNA, we posited that SNPs that 
disrupt essential RNA structures would be strongly selected against. For each structural model (no data, 
1M7 only, or three-reagent differential), we counted the number of SNPs that would lead to structural 
disruption by creating base pair mismatches. In the no-data model, 54 of the 105 SNPs were located in 
base-pairing positions; in the 1M7-only and three-reagent models, 46 and 38 SNPs would disrupt 
predicted structure respectively (Fig. 4.1e, left). The probabilities of selecting fewer disruptive positions 
by chance correspond to p-values of 0.35, 0.15 and 0.027 for the no-data, 1M7-only, and three-reagent 
models, respectively (Fig. 4.1e, right). Thus, with increasing data quality, the probability that SNPs are 
structurally disruptive by chance decreases significantly. This analysis suggests that the Xist secondary 
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Figure 4.1 Predicted structural architecture of the Xist lncRNA. (a) Ex vivo 1M7 reactivities are 
shown as the median reactivity over 55-nt sliding windows; values are plotted relative to the global 
median. (b) Shannon entropy values for the ex vivo secondary structure model, smoothed over 55-nt 
sliding windows, are plotted relative to the global median. High values indicate many possible structures, 
and vice-versa. Well-determined structures with low SHAPE reactivity and low Shannon entropy are 
emphasized with grey shading. (c) Base-pairing probabilities in the Xist RNA. Arcs represent base pairs 
and are colored by probability, with green arcs representing the most likely base pairs. (d) Minimum free 
energy secondary structure model of Xist obtained using SuperFold  (27) with differential three-reagent 
data. Examples of well-formed domains are colored according to SHAPE reactivity. (e) Left, positions of 
known SNPs in the Xist RNA relative to secondary structure models. For each model, a bootstrapped 
Gaussian cumulative probability density function (CDF; right) was used to determine the likelihood of 
encountering fewer disruptive SNPs than reported in the Structure Disrupted column.  
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structure model informed by three-reagent differential SHAPE data is broadly accurate and, additionally, 
emphasizes the importance of high-quality RNA structure probing data. Just as lack of selective pressure 
leads to increased SNP abundance in introns, pseudogenes, and other genetic elements with low 
functional potential (45), the observation that SNPs predominantly occur in locally unstructured regions 
strongly suggests that the structure of Xist is important for function. 
As part of our structure modeling approach, we assessed how well each secondary structure 
element was defined by both its sequence and the experimental SHAPE data by calculating Shannon 
entropies at nucleotide resolution (25, 27, 46) (Fig. 4.1b). RNA regions with high Shannon entropy likely 
sample multiple conformations, whereas those with low Shannon entropy likely adopt a single well-
defined structure. Previous work with large viral RNAs has shown that functional elements can be 
identified de novo as regions with both low SHAPE reactivity (indicating a high degree of structure) and 
low Shannon entropy (indicating well-defined structure) (25, 32). We identified 32 regions with low 
SHAPE reactivity and Shannon entropy in the Xist RNA (Fig. 4.1a-b). These individual structural 
domains resemble smaller lncRNAs such as steroid receptor RNA activator and HOTAIR, both of which 
exhibit extensive secondary structure (47, 48). The structure of Xist, and by inference many as-yet 
unstudied lncRNAs, is best described as a series of well-formed domains interlinked by flexible regions 
(Fig. 4.1c-d). Many of the most well-defined structural elements in Xist are located in the 3ʹ′ end of the 
RNA and have not been considered in previous studies (16, 49). The extent of defined structures in the 3ʹ′ 
end of Xist (Fig. 4.1c-d) suggests a functional basis for the conserved length of Xist transcripts. 
The 400-nt repeat A region at the 5ʹ′ end of Xist is one of the most clearly conserved regions of 
the RNA  (13-15). Repeat A is required for stable accumulation of spliced Xist in cells and for its function 
in gene silencing  (16, 20, 21). When this 400-nt region is expressed as a short transcript in the absence of 
the remainder of Xist, it is sufficient to induce repression of neighboring genes  (17). In the mouse, repeat 
A includes 7.5 copies of a 24-nt repeat unit separated by U-rich spacers of variable lengths. Current 
models of this region have emphasized self-contained structures consisting of stable stem-loops (16, 50-
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52). In contrast, in our model, based on data obtained in the context of full-length native Xist, the repeat A 
region generally lacks a defined global structure. A single small stem-loop, consisting of a GC-rich stem 
and AU-rich loop, is the only well-defined element in repeat A (Figs. 4.2a-b); these nucleotides exhibit 
high sequence conservation (Fig. 4.2c). This repeat A stem-loop motif is flanked by sequences with high 
Shannon entropies indicative of extensive structural variability (Fig. 4.2a). Furthermore, repeat A 
nucleotides likely interact, at least transiently, with adjacent segments of Xist (Fig. 4.2a). The inherently 
dynamic structure of repeat A may help the element interact with diverse subsets of proteins that 
accommodate its dual role in post-transcriptional processing of Xist and in gene silencing, respectively.  
Repeat E, which has no known function, also forms a dynamic and highly flexible structure. This 
region spans roughly 1 kb at the beginning of exon 7 and consists of U-rich repeat units approximately 
20-25-nts long (15). Repeat E exhibits low Shannon entropy and high SHAPE reactivity, indicating that it 
adopts an unstructured, mostly single-stranded conformation (Fig. 4.2d). Nucleotides in repeat E are 
clearly accessible for unencumbered interactions with RNA binding proteins. 
Our model also provides structural context for previously characterized Xist mutant phenotypes. 
For example, a 7.7-kb inversion of nucleotides 5,947-13,670 leads to a hypomorphic phenotype with 
incomplete silencing capabilities (53). This large inversion disrupts 14 structural elements in the Xist 
RNA model. A 16-nucleotide insertion located directly 3´ of the Repeat A region in Xist causes a similar 
hypomorphic phenotype (54). The insertion site falls in the middle of a well-defined hairpin structure 
with particularly low Shannon entropy (Fig. 4.1d, see arrowhead). This likely leads to a rearrangement of 
local structure that may affect the biological activity of the Repeat A region or, alternatively, attenuate a 
function of the hairpin element itself. 
The effects of the cellular environment on Xist structure 
Xist interacts with many cellular proteins (55-57), and we hypothesized that such interactions 
would be mediated by distinct, independently-functioning domains, featuring both single-stranded and 
well-structured motifs. To identify regions of Xist most strongly affected by the cellular environment, we 
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Figure 4.2 Structural features of repeat regions A and E. (a) Shannon entropy (top) and pairing 
probabilities for repeat A and the surrounding region (bottom). Probability arcs are colored based on 
probability with green likely (see scale). Only one high-probability stem-loop structure is predicted to 
occur within repeat A (grey shading). Other regions may interact with regions of Xist outside repeat A. (b) 
Secondary structure of the repeat A stem-loop. Nucleotides positions listed are relative to (Genbank 
accession no. NR_001463.3). (c) Sequence alignment of the stem-loop element for mouse, rat, cow, 
human, and monkey. Base pairs in the mouse structure are indicated in dot-bracket notation. Base-paired 
nucleotides are colored according to conservation. Nearly all base pairs are conserved (green), and most 
sequence variations maintain pairing potential through Hoogsteen (blue) or wobble interactions (yellow). 
(d) SHAPE reactivity (top) and Shannon entropy (middle) for the repeat E region. SHAPE reactivities are 
high and Shannon entropies are low throughout this region, indicating that it is likely largely unstructured 
as shown by the SHAPE-directed minimum free energy model of this region (bottom).  
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interrogated endogenous Xist structures in living cells using the 1M7 SHAPE reagent (Fig. 4.3a). We 
then evaluated absolute reactivity changes relative to ex vivo measurements. By searching for regions 
with an average absolute change greater than the global median, we identified 14 regions that are strongly 
affected by the cellular environment (Fig. 4.3b, purple shading). These regions overlap 16 well-defined 
RNA secondary structure domains and many dynamic regions (including repeats A and E). Prior work 
has shown that reduced in-cell SHAPE reactivities, relative to the ex vivo state, tend to report direct 
protein-RNA interactions, whereas increased reactivity in cells are often reflective of RNA 
conformational changes (30). By examining the relative contributions of positive and negative differences 
to the total absolute measured changes, we identified regions of Xist that likely interact with proteins and 
those that have different structures ex vivo and in vivo (Fig. 4.3c-d).  
Nucleotides in repeat E undergo striking changes in SHAPE reactivity; this region was reactive ex 
vivo but very unreactive in cells (Fig. 4.3b-d). There also appears to be extensive protein binding to 
Repeat D in cells.  There are notable changes in absolute SHAPE reactivity in repeat A, but these are not 
as strong as within other regions in Xist. We infer that repeat A forms RNA-protein interactions in cells 
but that these interactions are less stable or distinct than in other Xist motifs. The clear lack of structure in 
these repeat regions ex vivo suggests that nucleotides in these regions of Xist are poised for relatively 
unhindered access to proteins.  
We also observed large differences between ex vivo and in-cell data in regions that span many of 
the low SHAPE/low Shannon entropy domains in the ex vivo model (Fig. 4.3b-c; for example, positions 
12,300-12,700, 13,800-15,900, and 16,700-17,300). These data emphasize the diversity of in-cell 
interaction motifs encoded by Xist.  Regions that exhibit distinct changes in SHAPE reactivity in cells 
span nearly the entirety of the Xist RNA, are characterized by multiple distinct features, and are 





Figure 4.3 Effects of the cellular environment on Xist lncRNA structure. (a) Comparison of ex vivo 
(purple) and in-cell (green) SHAPE reactivities, plotted relative to the global median such that values 
above the line are more reactive than the median and those below the line are less reactive than the 
median. (b) The absolute change in SHAPE reactivity, computed over 50-nt sliding windows, is plotted 
over the length of Xist. Purple shading indicates regions that show the strongest differences in SHAPE 
reactivity when comparing ex vivo and in-cell data. Repeat E is characterized by a large absolute change, 
as are regions spanning 12,300-12,700, 13,800-15,900 and 16,700-17,300. Regions with low SHAPE 
reactivity and Shannon entropy are indicated with grey shading. (c) Contributions of positive (blue) and 
negative (red) reactivity differences to the total absolute change. In-cell values were subtracted from ex 
vivo values, such that positive differences represent reduced reactivity in cells, and vice versa. The sum of 
the blue and red areas equals the height of the black line in (b). (d) Ratio between positive and negative 
reactivity differences within regions of extensive reactivity change, highlighting the types of cellular 
effects that dominate each region. Values greater than 1 (above the line) indicate extensive in-cell 
protection, whereas those less than 1 (below the line) indicate enhanced reactivity in cells. Blue and red 
brackets indicate regions where protections or enhancements (or both) are most abundant. (e) Positive and 
negative ΔSHAPE sites. Blue sites are those which exhibit protection in cells while red sites indicate sites 
of enhanced reactivity, generally reporting protein binding and conformational changes, respectively.  
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Localized cellular effects on Xist structure 
Each individual reactivity measurement in a SHAPE experiment includes an error estimate (25), 
thus allowing for statistically rigorous analysis of local changes in RNA structure. We have developed a 
ΔSHAPE comparison framework that incorporates these error estimates and accurately identifies small, 
specific sites within an RNA likely to be bound by protein or undergo conformational changes (30). 
Positive and negative ΔSHAPE values indicate protection from versus enhanced reactivity in cells, 
respectively (30). The ∆SHAPE analysis complements the large-scale structural changes identified above, 
and helps define sites of specific protein interactions or conformational changes in the Xist lncRNA in 
cells. 
We identified ΔSHAPE sites throughout the length of Xist and found that the first 2.5 kb are 
largely lacking in ΔSHAPE sites, while in other regions they are abundant (Fig. 4.3e). Not surprisingly, 
regions with many ΔSHAPE sites are among those that exhibit strong absolute changes in SHAPE 
reactivity. We hypothesized that sequences critical to Xist-protein interactions may be over-represented 
among +ΔSHAPE sites and searched among them for sequence motifs. Our analysis revealed two highly 
abundant, U-rich sequence motifs, E1 and E2 (Fig. 4.4). These motifs are located exclusively within 
repeat E, and each motif contains a portion of the repeat unit. No additional significant sequence motifs, 
spanning ∆SHAPE sites, were identified outside of repeat E.  
To determine the location of specific protein interactions along the Xist molecule, we searched 
the protein crosslinking and immunoprecipitation database (CLIPdb) (58) for proteins previously 
identified as Xist partners in TSCs: CELF1, PTBP1, TARDBP, FUS, and RBFOX2 (55-57). We also 
performed digestion-optimized RIP-seq experiments in TSCs to identify binding sites for the HuR 
protein, an Xist-interacting protein (55). We expected proteins that bound stably to Xist during our 2-min 
probing period would perturb the RNA structure and yield clear ∆SHAPE signals.  For all proteins except 
RBFOX2, we identified CLIP or RIP sites that overlapped with positive and negative ΔSHAPE sites. We 
found that 79% of ΔSHAPE sites overlapped with CLIP or RIP sites, whereas only 47% of the total 
reported CLIP sites coincided with ΔSHAPE signals (Fig. 4.5a). This latter low number may reflect
  
Figure 4.4 Sequence motifs identified among ΔSHAPE sites. These sites, termed E1 and E2 for their 
location within repeat E, were identified from sites protected in cells according to ΔSHAPE analysis.  
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Figure 4.5 Correlation of ΔSHAPE sites with CLIP- and RIP-identified Xist-protein interactions. 
(a) Overlap between ΔSHAPE sites and CLIP- or RIP-identified sites. A subset of reported CLIP sites 
were confirmed as overlapping one or more ∆SHAPE sites for each protein with the exception of 
RBFOX2. Most ΔSHAPE-confirmed sites exhibit +ΔSHAPE changes (81% of total), while the 
remaining sites, confirmed only by –ΔSHAPE changes, may indicate proteins whose binding enhances 
SHAPE reactivity or correspond to non-specific sites that were incorrectly identified in CLIP 
experiments.  (b) Locations of CLIP or RIP protein binding sites that overlap with positive ΔSHAPE 
sites. Regions of large absolute change (purple shading) and well-formed structure (low SHAPE/low 
Shannon entropy; grey shading) are shown at the top. CLIP- or RIP-defined protein binding sites are 
shown as open circles; sites specifically confirmed by ∆SHAPE measurements as filled circles.  Data for 
CELF1, PTBP1, FUS, TARDBP and RBFOX2 were obtained from CLIP experiments (58); data for HuR 
were obtained using RIP (see Methods).  (c) Sequence motifs identified among ΔSHAPE-confirmed 
CELF1 (middle) and PTBP1 (bottom) binding sites are similar to the E1 motif (top), indicating a 
preferred recognition motif in Xist for these proteins. (d) Clustering of pairing probabilities from CLIP-
confirmed +ΔSHAPE sites reveal a structural preference for FUS binding. The average base-pairing 
probability is shown (top), derived from the major cluster of +ΔSHAPE sites within this region. (e) 
Structural context of the single ΔSHAPE-confirmed TARDBP binding site. The CLIP site is shaded grey. 
ΔSHAPE sites of in-cell protection and enhancement are boxed in blue and red, respectively. The splice 
junction between Xist exons 6 and 7 is highlighted.  
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differences between cell types, the high stringency used in the ΔSHAPE analysis (30), and the high 
background of CLIP experiments (59).  
Given the low false positive detection rate of protein binding identified by +ΔSHAPE (30), we 
chose to focus on CLIP sites corroborated by positive ΔSHAPE values. This enabled us to identify sites 
likely bound by CELF1, PTBP1, and HuR in repeat E, to show that sites for FUS are concentrated in the 
well-folded RNA domains spanning positions 13,900-15,000, and to define a single site bound by 
TARDBP at position 10,285 (Fig. 4.5b, filled circles). Remarkably, despite the relatively small number of 
proteins in our analysis, it is clear that the 3ʹ′ end of Xist is extensively involved in in-cell interactions. 
Furthermore, this analysis confirms that repeat E is a major protein-binding platform (Fig. 4.5b). 
ΔSHAPE-confirmed CELF1 and PTBP1 CLIP sites are located almost exclusively in repeat E 
(Fig. 4.5b). These proteins are associated with RNA processing (60, 61) and may help regulate Xist 
splicing or editing. We used sequence clustering to define consensus motifs from +ΔSHAPE-validated 
CLIP sites for CELF1 and PTBP1 and found that both overlap with motif E1 (Fig. 4.5c). No strong 
consensus sequence was identified among non-∆SHAPE-validated CLIP sites, indicating that repeat E 
interacts with CELF1 and PTBP1 in a sequence-specific manner. 
We identified HuR binding sites throughout repeat E (Fig. 4.5b). HuR has complex roles 
including promoting mRNA stability through interactions with AU-rich elements (AREs)  (62) and 
regulating nuclear RNA processing by repression splicing and increasing RNA stability to binding to 
intronic sequences  (63). HuR was widely detected throughout the U-rich repeat E. Within repeat E, the 
HuR RIP signal is very strong, and the defined binding sites are much larger than the CLIP-informed 
binding sites of other proteins. A search for consensus motifs within these large sites returned the 
repetitive unit of repeat E. When subsequences corresponding to +ΔSHAPE in-cell protections were used, 
a more nuanced consensus was returned that contains elements from motifs E1 and E2. In addition to the 
strong association with repeat E, we also detect HuR binding at the 5ʹ′ end of Xist, upstream of repeat A. 
This element, which is predicted to fold into three helices with large internal loops, exhibits both positive 
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and negative ΔSHAPE signals. The pattern of ΔSHAPE binding sites fits a model in which the multiple 
RNA recognition motifs in HuR both disrupt a helical element and bind to elements of sequence 
separated by 100 nts of primary sequence. Although functionality of the Xist 5ʹ′ end is usually attributed to 
repeat A, our data emphasize the importance of the 300 nucleotides 5ʹ′ of the repeat region. The strong 
association of HuR in two defined regions may affect the stability of Xist transcripts or regulate Xist via 
combinatorial interactions with other RBPs that bind in the same regions. 
Regions throughout Xist clearly serve as nucleation points for widespread interactions with 
proteins. FUS is an abundant, nuclear-enriched protein involved in the regulation of transcription, RNA 
processing, and DNA damage repair (64-67). Prior studies have shown that FUS binds to many RNAs 
(68). In contrast to the expectation of promiscuous binding, we find that in the context of full-length Xist 
RNA, +ΔSHAPE signals in CLIP sites indicative of FUS binding cluster strongly at nucleotides 13,000-
15,000 (Fig. 4.5b). This region has a well-defined RNA structure (Fig. 4.1) and exhibits a complex 
mixture of positive and negative ΔSHAPE sites (Figs. 4.3d-e). We analyzed the pairing probabilities of 
FUS-associated +ΔSHAPE sites within this region and identified a structural context for FUS binding: 
FUS-protected nucleotides tend to occur in single-stranded motifs closely flanked by base paired 
structures (Fig. 4.5d). FUS can facilitate RNA-induced multimerization (69), and forms dynamic, liquid-
like compartments in vivo (70), which may enable linkage of individual Xist molecules in the area that 
surrounds the inactive X (71-73). These observations are consistent with the abundant structural 
rearrangements we detect within the FUS-binding region, as the local increase in FUS concentration via 
multimerization may lead to widespread, likely cooperative, binding. 
In contrast to the multiple-site binding observed for CELF1, PTBP1, HuR, and FUS, ΔSHAPE 
analysis supports a single CLIP-identified binding site for the TARDBP protein (Fig. 4.5e). TARDBP is 
an RNA/DNA binding protein with a reported preference for UG-rich sequences (74, 75) and has been 
identified as both a transcription repressor (76, 77) and splicing regulator (74, 75, 78). The single site 
detected by our analysis is part of a UG-rich structural motif (nts 10,200-10,320) encompassing the splice 
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junction between exons 6 and 7 (Fig. 4.5e). In adult mouse brains depleted of TARDBP via antisense 
knockdown, incorrectly spliced Xist transcripts increase 2-fold and overall Xist transcript levels are 
reduced 3-fold (79), suggesting that TARDBP controls the amount of Xist present in a cell. Several 
TARDBP binding sites were identified by CLIPdb, but only a single site overlapped with a region of 
positive ΔSHAPE. The median SHAPE reactivity of this site was much higher than any other reported 
TARDBP CLIP site. We examined the reactivity of all other positive ΔSHAPE sites and found that most 
exhibit lower ex vivo SHAPE reactivities than the confirmed TARDBP site, ruling out the possibility that 
the single TARDBP site was detected solely because of high ex vivo reactivity. These data suggest the 
remaining TARDBP sites are occluded by RNA structure or are not sufficiently stable to cause a 
detectable reduction in SHAPE reactivity when in-cell data and ex vivo data are compared. More broadly, 
this analysis of TARDBP binding emphasizes the role that Xist RNA structure plays in modulating the 
specificity of protein binding. 
Conclusion 
Here we used the SHAPE-MaP quantitative nucleotide-resolution structure probing strategy to 
show that the Xist lncRNA has domains of well-defined secondary structure linked by unstructured or 
dynamic regions (Fig. 4.1). Repeat regions are generally unstructured, which appears to facilitate binding 
by protein cofactors (Figs. 4.1-4.5). We identified three distinct modes of action by which protein 
cofactors form stable interactions with Xist. In each case, protein interactions corroborated by CLIP-/RIP-
Seq and ΔSHAPE data are highly focused within specific structural elements. CELF1 and PTBP1 
exemplify widespread binding to accessible, unstructured regions. FUS binding occurred in a region with 
a well-defined structure ex vivo that undergoes extensive rearrangement in cells. In contrast, TARDBP 
bound predominantly to a single site contained within a small, well-defined structural domain. Finally, 
HuR makes multiple contacts within the repeat E region and binds to a small region at the 5ʹ′ end of Xist.  
In cross-referencing +ΔSHAPE sites with CLIP- and RIP-identified binding sites we have also 
shown ΔSHAPE to be a rigorous approach for identifying stable RNA-protein interaction sites (Fig. 4.5). 
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While CLIP studies have in several cases reported binding across the entire transcript, ΔSHAPE indicates 
that binding sites for a given protein tend to cluster, like those observed at repeat E and the FUS domain. 
In addition, only when +ΔSHAPE sites are analyzed is a distinct binding motif identified for HuR. 
ΔSHAPE also appears to detect specific interactions such as that observed at the TARDBP binding site. 
In general, ΔSHAPE analysis enables high confidence identification of RNA-protein interactions in a 
way that will be broadly useful in future studies of lncRNAs. 
Direct structural interrogation clearly shows that the internal structure of a lncRNA can be 
complex and diverse. This is unsurprising, given the varied functions carried out by this class of RNAs. 
At 18 kb, Xist is much longer than most lncRNAs, including the SRA and HOTAIR RNAs, whose 
structures have been characterized recently (47, 48). Like these other lncRNAs, the secondary structure of 
Xist is composed of distinct stable domains interspersed with regions that lack structure or that are 
structurally dynamic. These domains can now be used as a molecular roadmap, guiding future 
investigations into the mechanisms by which sequence elements embedded in Xist confer distinct 
biological activities, and how such elements contribute to XCI and lncRNA-induced gene silencing. 
Diverse protein complexes are required to accomplish many of the functions carried out by 
lncRNAs, and our structural analyses revealed multiple mechanisms by which lncRNAs can interact with 
protein partners to accomplish biological tasks. This ability to coordinate proteins via distinct, domain-
wise interactions may explain why certain lncRNAs are so long and why such RNAs are often capable of 
orchestrating epigenetic regulation on the kilobase to megabase scale (80-83). Our analysis of Xist 
supports the view that lncRNAs and other RNAs may have densely arrayed secondary structural features, 
exhibit multiple distinctive modes of protein interaction, and serve as multi-domain organizers of distinct 
cellular functions (84). 
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Methods 
In-cell RNA modification 
Mouse trophoblast stem cells were cultured as described (85). Live TSCs were washed once with 
PBS, and 900 μl of fresh growth media was added. For samples subjected to in-cell SHAPE probing, 100 
μl of 100 mM 1M7 in neat DMSO were added (10 mM final concentration) and immediately mixed by 
swirling the culture dish. Cells were then incubated at 37 °C for 5 minutes (but note that the structure 
probing reaction is complete in ~2 min). Media was removed and the cells were washed once with PBS 
before isolation of total RNA (1 mL TRIzol; Ambion). The no-reagent negative control RNA was 
prepared similarly with the exception that neat DMSO was used instead of 1M7 in DMSO. 
Ex vivo RNA extraction and modification 
Approximately 106 TSCs were washed and pelleted in ice-cold PBS, resuspended in 2.5 ml Lysis 
Buffer [40 mM Tris, pH 7.9, 25 mM NaCl, 6 mM MgCl2, 1 mM CaCl2, 256 mM sucrose, 0.5% Triton X-
100, 1,000 U/ml RNasin (Promega), 450 U/ml DNase I (Roche)], and rotated at 4 °C for 5 minutes. Cells 
were then pelleted at 4 °C for 2 minutes at 2250 g, resuspended in 40 mM Tris pH 7.9, 200 mM NaCl, 
1.5% SDS, and 500 μg/ml of Proteinase K, and rotated at 20 °C for 45 minutes. RNA was then extracted 
twice with phenol:chloroform:isoamyl alcohol (24:24:1) pre-equilibrated with 1× Folding Buffer (100 
mM HEPES, pH 8.0, 100 mM NaCl, 10 mM MgCl2), followed by one extraction with chloroform. RNA 
was exchanged into 1.1× Folding Buffer using a desalting column (PD-10, GE Life Sciences) and 
incubated at 37 °C for 20 minutes. Approximately 3 μg RNA was then added to a one-ninth volume of 
1M7, 1M6, or NMIA, each at 100 mM in neat DMSO (10 mM final concentration), and then incubated at 
37 °C for 5 minutes. Modified RNA was purified (RNeasy Midi spin column, Qiagen) and eluted in 
approximately 50 μl H2O. No- reagent negative control RNA was prepared in the same way except that 
neat DMSO was substituted for SHAPE reagent. 
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Denaturing control 
TSCs were grown as described (85), and total RNA was isolated using TRIzol (Ambion). 
Approximately 1.5 µg RNA was then resuspended in 150 µl 1.1× Denaturing Control Buffer [55 mM 
HEPES pH 8.0, 4.4 mM EDTA, 55% formamide (v/v)] and incubated at 95 °C for 1 minute.  
Aliquots of 45 µl of denatured RNA were then added to 5 µl of 100 mM 1M7, 1M6, or NMIA, 
and allowed to react at 95 °C for 1 minute. After modification, RNA was purified (RNeasy Mini spin 
column, Qiagen) and eluted in approximately 50 μl H2O. 
Xist SHAPE-MaP 
RNA was modified as described above. Mutational profiling reverse transcription reactions were 
primed with a mixture of Xist-specific primers (2 pmol each; Table 4.1) (25). The resulting cDNA was 
purified (Agencourt RNAClean XP beads, Beckman Coulter) and amplified by PCR (Q5 high-fidelity 
DNA polymerase, NEB) with Xist-specific primers (Table 4.1). These cDNAs (1.5 µL) were used as 
templates in individual 50 µl PCR reactions (1× Q5 Reaction Buffer, 200 µM dNTPs, 0.5 µM each 
primer, 0.02 U/µl Q5 high-fidelity DNA polymerase) using a touchdown format: 98 °C for 30 s, 25 cycles 
of [98 °C for 10 s, 72 °C for 30 s (decreasing by 1 °C per cycle until 60 °C), 72 °C for 30 s], 72 °C for 2 
min. The resulting amplicons were purified (Agencourt RNAClean XP beads, Beckman Coulter) and 
pooled according to experimental treatment before construction of high-throughput sequencing libraries 
(Nextera XT, Illumina) (27). 
Sequencing and SHAPE profile generation 
Purified sequencing libraries were pooled and sequenced on an Illumina MiSeq or HiSeq 
instrument, generating 2 × 150 or 2 × 100 paired-end datasets. SHAPE reactivity profiles were created by 
aligning reads to the Xist reference sequence (GenBank accession NR_001463.3) using ShapeMapper 
(v1.0, http://chem.unc.edu/rna/software.html). Final reactivity profiles were generated by excluding 
nucleotides 1-78, 2451-2599, and 17801-17918 and renormalizing the remaining nucleotides using the 
boxplot approach (43). In-cell 1M7 reactivities were then scaled such that the median SHAPE reactivity 
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in the 95th percentile matched the ex vivo value. Differential SHAPE reactivities between 1M6 and NMIA 
(44) were computed using a Z-factor test (25). 
Structure modeling 
Potential pseudoknots in Xist were identified using a sliding window approach (25) in which full-
length Xist was folded in 600-nt windows offset by 100-nt increments using ShapeKnots (43). Additional 
predictions were calculated at the 5ʹ′ and 3ʹ′ ends to increase sampling of terminal sequences and mitigate 
end effects. Predicted pseudoknots were inspected manually and retained if the structure was present in a 
majority of windows and if SHAPE reactivity was low on both sides of the potential helices. The model 
of ex vivo Xist secondary structure was created by providing SuperFold (25, 27) with 1M7 reactivities in 
addition to differential SHAPE values and pseudoknotted helices. SHAPE reactivities and Shannon 
entropies were smoothed over centered 55-nt sliding windows. Regions in which the local median was 
less than the global median for at least 40 nts were flagged as well-structured regions. Regions separated 
by fewer than 10 nts were combined before expanding regions to include all secondary structure contacts. 
SNP analysis 
Sequence variation data were obtained from the Sanger Institute (http://www.sanger.ac.uk). 
Positions of Xist exons were obtained from Ensembl (http://www.ensembl.org). The genomic exon 
locations were used to convert genomic SNP locations to their equivalent position on the Xist transcript. 
A multi-sequence alignment was performed to ensure agreement of SNP locations. We then examined 
whether SNP locations corresponded to base-paired or single-stranded conformations in our structure 
models. A bootstrapping approach was used to determine the likelihood of encountering fewer structure-
disrupting SNPs by chance. For 105 randomly chosen nucleotides, we recorded how many were base 
paired in a given structural model and iterated this process 100,000 times. We used the results to model a 
cumulative distribution function from which we calculated the probability of finding fewer disruptive 
SNPs than reported in the experimental data. 
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Conservation analysis 
Sequences of Xist loci from mouse (Mus musculus), rat (Rattus norvegicus), cow (Bos taurus), 
human (Homo sapiens), and rhesus macaque (Macaca mulatta) were obtained from the UCSC Genome 
Browser (86) and aligned with Clustal Omega (87). The RASL motif was then extracted from the 
alignment and analyzed for sequence conservation and covariation using R2R (88). 
Computing regions of large absolute reactivity changes 
The absolute value of the SHAPE reactivity difference between ex vivo and in-cell conditions was 
summed over 50-nt sliding windows. Total positive and negative changes were calculated in the same 
way, except the absolute value was not used. Regions of differences were defined as those in which 
absolute differences were greater than the global median over at least 100 consecutive nucleotides. 
Identifying protein binding sites and conformational changes with ΔSHAPE 
ΔSHAPE values were calculated by comparing the ex vivo and in-cell conditions as described 
(30) with the slight modification that differences greater than 20 (due to hyper-reactive nucleotides (29)) 
were excluded from analysis. The 798 nucleotides that differed significantly in reactivity between ex vivo 
and in-cell conditions were then grouped into 175 interaction sites by a sliding window approach. Five-
nucleotide windows were assessed for occupancy by at least three ΔSHAPE-identified nucleotides. 
Qualifying nucleotides within any adjacent windows meeting this criterion were pooled together as 
members of a single interaction site. 
Sites of CELF1, PTBP1, FUS, TARDBP, and RBFOX2 were downloaded from CLIPdb. These 
data represent sites of cellular interactions in mouse brain tissue (FUS, TARDBP, RBFOX2) and cultured 
myoblasts (CELF1 and PTBP1) and are expected to provide a high-level view of Xist-protein binding. 
Any CLIP sites that overlapped with a +ΔSHAPE site were selected as confirmed sites of protein 
interaction. 
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HuR RNA immunoprecipitation and sequencing 
Mouse trophoblast lysates were prepared according to the protocol described previously  (89). 
The RNA immunoprecipitation (RIP) of HuR-RNA complexes were also performed similarly, with the 
addition of micrococcal nuclease to partially digest RNA in the lysates before RIP. RNA fragments from 
the HuR RIP and total input RNA (treated with micrococcal nuclease) were made into cDNA libraries 
(NEBNext Small RNA Library Prep, NEB), and then sequenced (Illumina Hi-Seq 2500). Raw reads from 
the digestion-optimized RIP libraries were preprocessed to remove adapter sequences and PCR artifacts. 
Preprocessed reads were mapped to the mouse genome (mm9) using TopHat (90). Uniquely mapped 
reads from the RIP were normalized to the input reads across the genome, and log of odds ratios 
calculated for each site using a mixture model approach as previously described (91). HuR binding sites 
were defined as regions with a log-odds score in the 95th percentile of all HuR sites transcriptome-wide.  
Identification of sequence motifs among ΔSHAPE-identified interaction sites 
Sequences corresponding to interaction sites associated with positive ΔSHAPE sites were 
extracted and expanded to 20 nts. These sequences were then searched for sequence motifs with MEME 
(92), allowing for at least two sites per motif, a minimum motif length of four nucleotides, and allowing 
any number of motifs per input sequence. The nucleotide distribution of the Xist transcript was used as 
the background when calculating significance. Searching in this manner yielded sequence motifs E1 and 
E2 with expectation values 1.4×10–36 and 8.7×10–29, respectively. Sequence motifs within ΔSHAPE-
confirmed CLIP sites were analyzed in the same way. This identified motifs represented in the CELF1 
and PTBP1 binding sites with expectation values of 9.3×10–40 and 4.5×10–17, respectively. 
Clustering Fus-localized positive ΔSHAPE sites by pairing probability 
Total pairing probabilities for each nucleotide in expanded +ΔSHAPE sites (see above) were 
extracted from the partition function using RNAtools (http://www.github.com/grice/RNAtools). Sites 
were then sorted by uncentered absolute correlation similarity into three clusters by k-means clustering 
implemented with Cluster 3.0 (93). Clusters were visualized using TreeView (94). 
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Evaluation of TARDBP antisense knock-down data 
TARDBP protein levels were previously depleted by targeting RNase H to the TARDBP pre-
mRNA with antisense DNA oligonucleotides (79). RNA-seq reads for control and TARDBP knock-down 
samples (4 replicates each) were downloaded from the Gene Expression Omnibus (accession no. 
GSE27394). Adapter sequences were removed and filtered for base call quality before alignment to the 
mouse genome (mm10) with Bowtie2 (95). The number of reads overlapping introns was then computed 
and compared to exon-aligned reads. 
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Amplicon name Forward primer Reverse primer (RT primer) 
Amp_22 TCCATCTAAGGAGCTTTGGG ATAGGTTCACTCACACAGCA 
Amp_21 GCTTGGTGGATGGAAATATGG CGTTATACCGCACCAAGAAC 
Amp_20 AGCGGACTGGATAAAAGCAAC CATCACAGTCTAATTCCATCCTG 
Amp_19 TGTTGGTGTTTGCTTGACTTCC AAACTTTAAGGACTCCAAAGTAAC 
Amp_18 CGTCTGATAGTGTGCTTTGC GGCTTGGGATAGGTCTGAAA 
Amp_RepC CCAGGCCCAGATACTTTCAG TGTTTGCCCCTTTGCTAAAT 
Amp_16 CCCATCTATACCCCCTCCAT GCAAGGGTAGTATTAGGACCTTGAG 
Amp_15 TCACATGCTTTCTTATTTCAGCC AGTTAACACTGTGCACATTTAC 
Amp_14 GGTTCCTACCACTATGCCCTG AAAACCCCATCCTTTATGCAA 
Amp_13 AAACCCTTTTGCAGTACAGC GCCTCTGGTGTCAAAAGAGTAC 
Amp_12 AGCAGAAAGAGGGTTGTACG TGATGGAATTGAGAAAGGGCAC 
Amp_11 TCCATTGACCACTTTTCTGAATCAC AAGATACTTGTCTTAAACATTCTGC 
Amp_10 TACTGAGGGTGATGAGTCTGT TCAGCAATGTCATATCAAACAC 
Amp_9 CTCAGACAACAATGGGAGCT GCATTCTTTGAGCCTTTGTCT 
Amp_8 ACAAAAAGCTTACAGGCCACA AATAGACACAAAGCAAGGAAG 
Amp_7 TGAGTGTGTATTGTGGGTGTGT ACACTGCAGACAGAAAAGAC 
Amp_6 GTCTCCTTGTGTTGTCTAATTCG TTCTGGACCTATTGGGAAGGG 
Amp_5 TTGTGTCTCTTTGCTATTGGTGG TTCCTTTATGGGCAATGGCAAC 
Amp_4 CCCAGCATCCCTTTCCATTTC AATTGCCAATGTGCTATGAG 
Amp_3 AGGACTACTTAACGGGCTTA AGGGTAATCAATCACCTGCA 
Amp_2 TAAGGCCAGTGTGTTTCTTC ACACATGGGAGACAATATTTAGC 
Amp_1 AACCTGGGTGTGTTAGCATG AAGTGCTACATAATGCTAGAAAG 
Amp_0 TGGCTGAAACTTAATCATAATGC CTGGGCATGGGTTAAGCA 
Amp_-1 GAGACATGGTCTCATAAAGCC TGTGTGGAACCGAGGAAATA 
Amp_-2 TGATGAAAGTGCAGTTCTAAGTA TTGCCCCAGGATAATGCAAA 
Amp_-3 TAGGCCATTTTAGCTATGACTGT TTTGAACTCCCAGACCTCTTC 
Amp_-4 AGTTGCCTTAGAGCTGAAGT TTGTGACATGTTGGTAAGCA 
 
Table 4.1. Primer sequences used to create Xist amplicons. Amplicons generated with these primers 
enable specific, transcript-wide structural interrogation of the Xist RNA in the context of total mouse 
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